Chronically Injured Corticospinal Axons	1
Cross Large Spinal Lesion Gaps	48
Cross	48
Large Spinal Lesion Gaps	54
a Multifactorial Transplantation Strategy Using Olfactory Ensheathing Cell/Olfactory Nerve Fibroblast-Biomatrix Bridges R. Deumens ,1 * G.C. Koopmans ,1,2 W.M.M. Honig ,2 V. Maquet ,3 R. Je ' roˆme ,3 H.W.M. Steinbusch ,1 and E.A.J. Joosten2 1Department of Psychiatry and Neuropsychology , Division Neuroscience , European Graduate School of Neuroscience -LRB- EURON -RRB- , University of Maastricht , Maastricht , The Netherlands 2Department of Anesthesiology , Academic Hospital Maastricht , Maastricht , The Netherlands 3Center for Education and Research on Macromolecules , University of Lie ` ge , Lie ` ge , Belgium Transplantation of mixed cultures containing olfactory ensheathing cell	85
a Multifactorial Transplantation Strategy	85
Olfactory Ensheathing Cell/Olfactory Nerve Fibroblast-Biomatrix Bridges R. Deumens ,1 *	133
Olfactory Ensheathing Cell/Olfactory Nerve Fibroblast-Biomatrix Bridges R. Deumens ,1	133
Olfactory Ensheathing Cell/Olfactory Nerve	133
Fibroblast-Biomatrix Bridges R. Deumens ,1	176
G.C. Koopmans ,1,2 W.M.M. Honig ,2 V. Maquet ,3	219
R. Je ' roˆme ,3 H.W.M. Steinbusch ,1 and E.A.J. Joosten2 1Department of Psychiatry and Neuropsychology	264
R. Je ' roˆme	264
R. Je '	264
,3 H.W.M. Steinbusch ,1 and E.A.J. Joosten2 1Department of Psychiatry and Neuropsychology	275
,3 H.W.M. Steinbusch ,1 and E.A.J. Joosten2 1Department	275
Psychiatry and Neuropsychology	333
Division Neuroscience , European Graduate School of Neuroscience -LRB- EURON -RRB- , University of Maastricht , Maastricht , The Netherlands 2Department of Anesthesiology , Academic Hospital Maastricht , Maastricht , The Netherlands 3Center for Education and Research on Macromolecules , University of Lie ` ge , Lie ` ge ,	365
Division Neuroscience	365
European Graduate School	388
Neuroscience	416
EURON	430
University of Maastricht	438
University	438
Maastricht	452
Maastricht	464
The Netherlands 2Department of Anesthesiology	476
The Netherlands 2Department	476
Anesthesiology	507
Academic Hospital Maastricht	523
Maastricht	553
The Netherlands 3Center for Education and Research on Macromolecules	565
The Netherlands 3Center	565
Education and Research	593
Macromolecules	619
University of Lie ` ge	635
University	635
Lie ` ge	649
Lie ` ge	657
Lie	657
ge	661
Belgium Transplantation of mixed cultures containing olfactory ensheathing cell	665
Belgium Transplantation	665
mixed cultures containing olfactory ensheathing cell	694
mixed cultures	694
olfactory ensheathing cell	720
OEC	748
olfactory nerve fibroblasts -LRB- ONF -RRB-	757
olfactory nerve fibroblasts	757
ONF	786
regrowth of both acutely and chronically injured corticospinal -LRB- CS -RRB- axons across small spinal cord lesion gaps	819
regrowth	819
both acutely and chronically injured corticospinal -LRB- CS -RRB- axons across small spinal cord lesion gaps	831
chronically injured corticospinal -LRB- CS -RRB- axons across small spinal cord	848
chronically injured corticospinal -LRB- CS -RRB- axons	848
CS	883
small spinal cord	900
we	937
a multifactorial transplantation strategy	945
regrowth of chronically injured CS axons	1000
regrowth	1000
chronically injured CS axons	1012
large spinal cord lesion gaps	1048
This strategy	1079
the transplantation of aligned OEC/ONF-biomatrix complexes , as described previously -LRB- Deumens et al. -LSB- 2004 -RSB- Neuroscience 125:591 -- 604 -RRB-	1102
the transplantation	1102
OEC/ONF-biomatrix complexes	1133
Deumens et al. -LSB- 2004 -RSB- Neuroscience 125:591 -- 604	1187
Deumens et al. -LSB-	1187
2004 -RSB- Neuroscience 125:591 -- 604	1203
2004	1203
Neuroscience 125:591 -- 604	1209
the lesion gap with additional OEC/ONF injections rostral and caudal	1243
the lesion gap	1243
additional OEC/ONF injections rostral and caudal	1263
additional OEC/ONF injections	1263
the lesion site	1315
We	1332
an enhanced presence of injured CS axons	1340
an enhanced presence	1340
injured CS axons	1364
the lesion gap	1401
no effects on injured CS axons	1422
no effects	1422
injured CS axons	1436
the lesion gap	1469
injured CS axons	1498
the OEC/ONFbiomatrix complex	1533
the lesion gap	1569
The enhanced presence of CS axons rostral to the lesion gap	1585
The enhanced presence	1585
CS axons rostral to the lesion gap	1610
CS axons rostral	1610
the lesion gap	1630
any recovery of behavioral parameters assessed with the BBB locomotor rating scale or Cat	1668
any recovery	1668
behavioral parameters assessed with the BBB locomotor rating scale or Cat	1684
behavioral parameters	1684
the BBB locomotor rating scale or Cat	1720
the BBB locomotor rating scale	1720
Cat	1754
gait analysis	1764
We	1779
our multifactorial transplantation strategy	1796
an OEC/ONF continuum	1870
the injured spinal cord	1894
regrowth of injured CS axons across large spinal lesion gaps	1940
regrowth	1940
injured CS axons across large spinal lesion gaps	1952
injured CS axons	1952
large spinal lesion gaps	1976
VVC 2006 Wiley-Liss , Inc. .	2002
VVC 2006	2002
Wiley-Liss , Inc.	2011
Repair strategies in experimental spinal cord injury -LRB- SCI -RRB-	2030
Repair strategies	2030
experimental spinal cord injury -LRB- SCI -RRB-	2051
experimental spinal cord injury	2051
SCI	2084
regrowth of severed axons	2121
regrowth	2121
severed axons	2133
those of the corticospinal -LRB- CS -RRB- tract	2158
those	2158
the corticospinal -LRB- CS -RRB- tract	2167
The success of many repair strategies	2197
The success	2197
many repair strategies	2212
the time	2275
injury -LRB- Houle and Tessler , 2003 -RRB-	2290
injury	2290
Houle and Tessler , 2003	2298
Houle	2298
Tessler , 2003	2308
Tessler	2308
2003	2317
This	2324
a changing environment of the injured spinal cord and a change in the intrinsic capacity of injured neurons to regrow	2346
a changing environment	2346
the injured spinal cord and a change in the intrinsic capacity of injured neurons to regrow	2372
the injured spinal cord	2372
a change in the intrinsic capacity of injured neurons to regrow	2400
a change	2400
the intrinsic capacity of injured neurons	2412
the intrinsic capacity	2412
injured neurons	2438
the initial -LRB- acute -RRB- stages after injury	2472
the initial -LRB- acute -RRB- stages	2472
injury	2505
inflammatory processes and alterations in the extracellular matrix -LRB- ECM -RRB-	2513
inflammatory processes and alterations	2513
the extracellular matrix -LRB- ECM -RRB-	2555
the extracellular matrix	2555
ECM	2581
Dusart and Schwab , 1994 ; Tang et al. , 2003	2599
Dusart and Schwab	2599
1994 ; Tang et al.	2618
1994	2618
Tang et al.	2624
Tang	2624
et al.	2629
2003	2637
chronic	2651
stages	2660
fibroglial scarring and the formation of large cystic cavities -LRB- Schwab and Bartholdi , 1996 ; Tang et al. , 2003 ; Silver and Miller , 2004 -RRB-	2688
fibroglial scarring	2688
the formation of large cystic cavities -LRB- Schwab and Bartholdi , 1996 ; Tang et al. , 2003 ; Silver and Miller , 2004 -RRB-	2712
the formation	2712
large cystic cavities -LRB- Schwab and Bartholdi , 1996 ; Tang et al. , 2003 ; Silver and Miller , 2004 -RRB-	2729
large cystic cavities	2729
Schwab and Bartholdi , 1996 ; Tang et al. , 2003 ; Silver and Miller , 2004	2752
Schwab and Bartholdi , 1996 ; Tang et al.	2752
Schwab and Bartholdi , 1996	2752
Schwab and Bartholdi	2752
1996	2774
Tang et al.	2780
Tang	2780
et al.	2785
2003 ; Silver	2793
2003	2793
Silver	2799
Miller , 2004	2810
Miller	2810
2004	2818
addition	2828
neurons	2846
growth-associated genes	2876
a sprouting response -LRB- Skene , 1989 ; Tetzlaff et al. , 1991 ; Kost and Oblinger , 1993 -RRB-	2912
a sprouting response	2912
Skene , 1989 ; Tetzlaff et al. , 1991 ; Kost and Oblinger , 1993	2934
Skene , 1989 ; Tetzlaff et al.	2934
Skene , 1989	2934
Skene	2934
1989	2941
Tetzlaff et al.	2947
Tetzlaff	2947
et al.	2956
1991 ; Kost	2964
1991	2964
Kost	2970
Oblinger , 1993	2979
Oblinger	2979
1993	2989
time	3011
the severed neurons	3017
growth-associated genes -LRB- Houle et al. , 1998 ; Houle and Tessler , 2003 -RRB-	3051
growth-associated genes	3051
Houle	3076
et al. , 1998 ; Houle and Tessler , 2003	3082
et al.	3082
1998 ; Houle and Tessler	3090
1998	3090
Houle and Tessler	3096
2003	3115
their axons	3133
the injury site -LRB- Pallini et al. , 1988 ; Hill et al. , 2001 -RRB- , a process called axonal die-back	3150
the injury site -LRB- Pallini et al. , 1988 ; Hill et al. , 2001 -RRB-	3150
the injury site	3150
Pallini	3167
et al. , 1988 ; Hill et al. , 2001	3175
et al.	3175
1988 ; Hill et al.	3183
1988	3183
Hill et al.	3189
Hill	3189
et al.	3194
2001	3202
a process called axonal die-back	3209
a process	3209
axonal die-back	3226
Most repair strategies	3243
cell transplantation	3277
the growth-promoting properties of the injured spinal cord environment	3323
the growth-promoting properties	3323
the injured spinal cord environment	3358
the last decade	3398
transplantation of olfactory glia	3415
transplantation	3415
olfactory glia	3434
much attention	3462
the putative capacity of these cells	3488
the putative capacity	3488
these cells	3513
the injured spinal cord	3535
Transplantation of mixed cultures of olfactory ensheathing cells -LRB- OEC -RRB- and olfactory nerve fibroblasts -LRB- ONF -RRB-	3560
Transplantation	3560
mixed cultures of olfactory ensheathing cells -LRB- OEC -RRB- and olfactory nerve fibroblasts -LRB- ONF -RRB-	3579
mixed cultures	3579
olfactory ensheathing cells -LRB- OEC -RRB- and olfactory nerve fibroblasts -LRB- ONF -RRB-	3597
olfactory ensheathing cells	3597
OEC	3626
olfactory nerve fibroblasts	3635
ONF	3664
regrowth of acutely injured CS axons	3684
regrowth	3684
acutely injured CS axons	3696
small spinal lesion gaps and partial functional recovery -LRB- Li et al. , 1997 , 1998 , 2003 -RRB-	3728
small spinal lesion gaps and partial functional recovery	3728
spinal lesion gaps	3734
Li	3786
et al. , 1997 , 1998 , 2003	3789
et al.	3789
1997	3797
1998	3803
2003	3809
Studies in which purified OEC cultures were used	3816
Studies	3816
purified OEC cultures	3833
similar results : regrowth of acutely injured CS axons	3872
similar results	3872
regrowth of acutely injured CS axons	3889
regrowth	3889
acutely injured CS axons	3901
small lesion gaps and partial functional recovery -LRB- Ramon - Cueto et al. , 2000 ; Lu et al. , 2001 ; Nash et al. , 2002 -RRB-	3933
small lesion gaps	3933
partial functional recovery -LRB- Ramon - Cueto et al. , 2000 ; Lu et al. , 2001 ; Nash et al. , 2002 -RRB-	3955
partial functional recovery	3955
Ramon	3984
Cueto et al. , 2000 ; Lu et al. , 2001 ; Nash et al. , 2002	3991
Cueto	3991
et al. , 2000 ; Lu et al. , 2001 ; Nash et al. , 2002	3997
et al. , 2000	3997
et al.	3997
2000	4005
Lu et al. , 2001	4011
Lu	4011
et al. , 2001	4014
et al.	4014
2001	4022
Nash et al. , 2002	4028
Nash	4028
et al. , 2002	4033
et al.	4033
2002	4041
Stimulation of long-distance regrowth of chronically injured CS axons across clinically relevant , large spinal lesion gaps	4048
Stimulation	4048
long-distance regrowth of chronically injured CS axons across clinically relevant , large spinal lesion gaps	4063
long-distance regrowth	4063
chronically injured CS axons across clinically relevant , large spinal lesion gaps	4089
chronically injured CS axons	4089
clinically relevant , large spinal lesion gaps	4125
The use of mixed OEC	4197
The use	4197
mixed OEC	4208
ONF cultures	4219
this respect for two reasons	4252
this respect	4252
two reasons	4269
OEC and ONF	4289
the process of long-distance axon regeneration in the olfactory system -LRB- Li et al. , 2005 -RRB-	4337
the process	4337
long-distance axon regeneration in the olfactory system -LRB- Li et al. , 2005 -RRB-	4352
long-distance axon regeneration	4352
the olfactory system -LRB- Li et al. , 2005 -RRB-	4387
the olfactory system	4387
Li	4409
et al. , 2005	4412
et al.	4412
2005	4420
regrowth of chronically injured CS axons across small spinal lesion gaps	4435
regrowth	4435
chronically injured CS axons across small spinal lesion gaps	4447
chronically injured CS axons	4447
small spinal lesion gaps	4483
transplantation of mixed OEC/ONF cultures -LRB- Keyvan-Fouladi et al. , 2003 -RRB-	4532
transplantation	4532
mixed OEC/ONF cultures -LRB- Keyvan-Fouladi et al. , 2003 -RRB-	4551
mixed OEC/ONF cultures	4551
Keyvan-Fouladi	4575
et al. , 2003	4590
et al.	4590
2003	4598
the present study	4608
we	4627
delayed OEC/ONF transplantation into 2-mm-long dorsal hemisection lesions	4643
delayed OEC/ONF transplantation	4643
2-mm-long dorsal hemisection lesions	4680
Four weeks	4718
the time of delay	4745
the time	4745
delay	4757
this time	4772
a chronic spinal cord injury -LRB- Houle and Tessler , 2003 -RRB-	4806
spinal cord injury -LRB- Houle and Tessler , 2003 -RRB-	4816
spinal cord injury	4816
Houle and Tessler , 2003	4836
Houle	4836
Tessler , 2003	4846
Tessler	4846
2003	4855
large cavitations	4879
millions of OEC/ONF	4915
millions	4915
OEC/ONF	4927
we	4936
an aligned OEC/ONF-biomatrix complex -LRB- Deumens et al. , 2004 -RRB-	4944
an aligned OEC/ONF-biomatrix complex	4944
Deumens	4982
et al. , 2004	4990
et al.	4990
2004	4998
a continuum of OEC/ONF	5015
a continuum	5015
OEC/ONF	5030
the injured spinal cord instead of having an isolated OEC / ONF transplant within the lesion site , additional OEC /	5044
the injured spinal cord	5044
an isolated OEC / ONF transplant within the lesion site , additional OEC /	5086
an isolated OEC	5086
ONF transplant within the lesion site , additional OEC	5103
ONF transplant	5103
the lesion site , additional OEC	5125
ONF injections	5158
the rostral and caudal host stumps	5188
the rostral	5188
caudal host stumps	5204
We	5224
our multifactorial transplantation strategy -LRB- OEC/ONF-biomatrix plus OEC/ONF cell injections -RRB-	5245
our multifactorial transplantation strategy	5245
OEC/ONF-biomatrix plus OEC/ONF cell injections	5290
OEC/ONF-biomatrix	5290
OEC/ONF cell injections	5313
regrowth of injured CS axons across large lesion gaps	5349
regrowth	5349
injured CS axons across large lesion gaps	5361
injured CS axons	5361
large lesion gaps	5385
We	5404
a recovery	5430
the locomotor parameter stride length of the hind limbs	5444
the locomotor parameter stride length	5444
the hind limbs	5485
this parameter	5509
the integrity of the CS tract -LRB- Starkey et al. , 2005 -RRB-	5553
the integrity	5553
the CS tract -LRB- Starkey et al. , 2005 -RRB-	5570
the CS tract	5570
Starkey	5584
et al. , 2005	5592
et al.	5592
2005	5600
we	5615
the effects of the complete multifactorial approach	5637
the effects	5637
the complete multifactorial approach	5652
control animals	5690
culture medium injections	5720
the host stumps	5751
the injection procedure	5782
MATERIALS AND METHODS	5808
Study Design All experimental procedures were performed according to the recommendations of the European Commission	5830
Study Design All	5830
experimental procedures	5847
the recommendations of the European Commission	5899
the recommendations	5899
the European Commission	5922
European Communities Council Directive of 24 November 1986 ; 86/609/EEC	5947
European Communities Council Directive	5947
24 November 1986 ; 86/609/EEC	5989
24 November 1986	5989
24	5989
November 1986	5992
86/609/EEC	6007
protocols	6024
the Committee	6051
Animal Research of the Maastricht University -LRB- DEC 2004 - 030 -RRB-	6068
Animal Research	6068
the Maastricht University -LRB- DEC 2004 - 030 -RRB-	6087
the Maastricht University	6087
DEC 2004 - 030	6114
DEC 2004	6114
030	6124
this study	6133
every attempt	6145
the number of animals and their suffering	6180
the number	6180
animals and their suffering	6194
animals	6194
their suffering	6206
Adult male Lewis rats -LRB- inbred , animal facilities of Maastricht University -RRB-	6223
Adult male Lewis rats	6223
inbred , animal facilities of Maastricht University	6246
inbred , animal facilities	6246
Maastricht University	6275
CatWalk gait analysis -LRB- Hamers et al. , 2001 -RRB-	6318
CatWalk gait analysis	6318
Hamers	6341
et al. , 2001	6348
et al.	6348
2001	6356
the age of 7 -- 9 weeks	6365
the age of 7	6365
the age	6365
7	6376
9 weeks	6378
the age of 9 weeks	6390
the age	6390
9 weeks	6401
the animals	6410
a dorsal hemisection injury	6440
T11/T12	6471
the following 4 weeks	6487
the animals	6510
both the conventional BBB locomotor rating scale -LRB- Basso et al. , 1995 -RRB- and the CatWalk gait analysis -LRB- Hamers et al. , 2001 -RRB-	6553
the conventional BBB locomotor rating scale -LRB- Basso et al. , 1995 -RRB-	6558
the conventional BBB locomotor rating scale	6558
Basso	6603
et al. , 1995	6609
et al.	6609
1995	6617
the CatWalk gait analysis -LRB- Hamers et al. , 2001 -RRB-	6627
the CatWalk gait analysis	6627
Hamers	6654
et al. , 2001	6661
et al.	6661
2001	6669
4 weeks after dorsal hemisection	6679
4 weeks	6679
dorsal hemisection	6693
the animals	6713
two groups	6743
One group of animals -LRB- n = 8 -RRB-	6755
One group	6755
animals -LRB- n = 8 -RRB-	6768
animals	6768
n	6777
8	6781
a multifactorial transplantantion strategy	6809
the other group -LRB- n = 8 -RRB-	6857
the other group	6857
n	6874
8	6878
the control group -LRB- see below -RRB-	6891
the control group	6891
This transplantation strategy	6922
OEC / ONF complexes	6987
OEC	6987
ONF complexes	6992
the lesion site	7011
OEC/ONF suspensions rostral and caudal	7041
OEC/ONF suspensions	7041
the lesion site	7083
the following 12 weeks	7107
the animals	7131
using the above-mentioned locomotor tests ; at 9 weeks after transplantation , i.e. , 13 weeks after SCI , the CS tract was anterogradely traced by using biodextran amine -LRB- BDA -RRB-	7174
the above-mentioned locomotor tests	7180
9 weeks	7220
transplantation	7234
13 weeks after SCI , the CS tract was anterogradely traced by using biodextran amine -LRB- BDA -RRB-	7257
13 weeks	7257
SCI	7272
the CS tract	7277
biodextran amine -LRB- BDA -RRB-	7324
biodextran amine	7324
BDA	7342
16 weeks after SCI	7351
16 weeks	7351
SCI	7366
the animals	7371
histological analysis	7423
the postoperative period	7457
histological analysis	7493
the researchers	7516
the treatment	7546
OEC/ONF and Biomatrix Complexes Syngeneic OEC/ONF	7561
OEC/ONF	7561
Biomatrix Complexes Syngeneic OEC/ONF	7573
Biomatrix Complexes	7573
Syngeneic OEC/ONF	7593
the outer two glomerular layers of adult Lewis rat	7630
the outer two glomerular layers	7630
adult Lewis rat	7665
olfactory bulbs by methods described elsewhere -LRB- Ramon-Cueto and Nieto-Sampedro , 1992 -RRB- , but without purification	7681
olfactory bulbs	7681
methods described elsewhere -LRB- Ramon-Cueto and Nieto-Sampedro , 1992 -RRB-	7700
methods	7700
Ramon-Cueto and Nieto-Sampedro , 1992	7729
Ramon-Cueto and Nieto-Sampedro	7729
1992	7761
purification	7780
9-week-old Lewis rats , bred at the animal facilities of Maastricht University ,	7803
9-week-old Lewis rats	7803
the animal facilities of Maastricht University	7834
the animal facilities	7834
Maastricht University	7859
The olfactory bulbs	7900
meninges	7950
careful dissection of the outer two glomerular layers	7972
careful dissection	7972
the outer two glomerular layers	7994
The tissue	8027
small fragments	8053
trypsin	8088
0.1 % in phosphate-buffered saline ; Gibco	8097
0.1 %	8097
phosphate-buffered saline ; Gibco	8105
phosphate-buffered saline	8105
Gibco	8132
Invitrogen , Breda , The Netherlands	8139
Invitrogen	8139
Breda	8151
The Netherlands	8158
378C for 15 min	8178
378C	8178
15 min	8187
Trypsinization	8195
addition of culture medium	8225
addition	8225
culture medium	8237
Dulbecco 's	8253
Eagle 's medium -LRB- DMEM/NUT mix F12 ; Gibco / Invitrogen -RRB- with glutamax-I supplemented with 10 %	8273
Eagle 's medium	8273
Eagle 's	8273
DMEM/NUT mix F12 ; Gibco / Invitrogen	8289
DMEM/NUT mix F12	8289
Gibco / Invitrogen	8307
Gibco	8307
Invitrogen	8314
glutamax-I supplemented with 10 %	8331
glutamax-I	8331
10 %	8360
fetal calf serum -LRB- Bodinco , Alkmaar , The Netherlands -RRB- and antibiotics -LRB- 100 U/ml penicillin and 100 µg/ml streptomycin -RRB-	8376
fetal calf serum -LRB- Bodinco , Alkmaar , The Netherlands -RRB-	8376
fetal calf serum	8376
Bodinco	8394
Alkmaar	8403
The Netherlands	8412
antibiotics -LRB- 100 U/ml penicillin and 100 µg/ml streptomycin -RRB-	8433
antibiotics	8433
100 U/ml penicillin and 100 µg/ml streptomycin	8446
100 U/ml penicillin	8446
100 µg/ml streptomycin	8470
the tissue	8501
culture medium	8534
it	8550
1 ml of culture medium	8570
1 ml	8570
culture medium	8578
Single-cell dissociation	8594
mechanical trituration	8635
The cultures that are obtained by this procedure	8659
The cultures	8659
this procedure	8693
a mixed population of OEC and ONF -LRB- OEC/ONF -RRB- , as described previously -LRB- Li et al. , 1998 , Deumens et al. , 2004 -RRB-	8717
a mixed population	8717
OEC and ONF -LRB- OEC/ONF -RRB- , as described previously	8739
OEC and ONF -LRB- OEC/ONF -RRB-	8739
OEC and ONF	8739
OEC/ONF	8752
Li	8787
et al. , 1998 , Deumens et al. , 2004	8790
et al.	8790
1998 , Deumens et al.	8798
1998	8798
Deumens et al.	8804
Deumens	8804
et al.	8812
2004	8820
The OEC/ONF cultures	8827
poly-L-lysine-coated Petri dishes	8863
a density of 200,000 cells in 2 ml of culture medium per Petri dish	8900
a density	8900
200,000 cells in 2 ml of culture medium per Petri dish	8913
200,000 cells	8913
2 ml of culture medium per Petri dish	8930
2 ml	8930
culture medium per Petri dish	8938
culture medium	8938
Petri dish	8957
The cells	8969
4	8994
5 days in vitro -LRB- DIV -RRB- before half of the culture medium	8996
5 days	8996
-LRB- DIV -RRB- before half of the culture medium	9012
-LRB- DIV -RRB-	9012
half of the culture medium	9025
half	9025
the culture medium	9033
the culture medium	9079
every 2 days	9112
DIV10	9129
a subset of the OEC/ONF cultures	9136
a subset	9136
the OEC/ONF cultures	9148
the Petri dishes	9188
them	9213
PLA/PLA-b-PEO matrices that were used for transplantation into the spinal lesion site	9221
PLA/PLA-b-PEO matrices	9221
transplantation	9263
the spinal lesion site	9284
the rest of the OEC/ONF cultures	9312
the rest	9312
the OEC/ONF cultures	9324
the Petri dishes	9363
intraspinal OEC/ONF injections	9393
Collection of the OEC/ONF cultures from the Petri dishes	9425
Collection	9425
the OEC/ONF cultures from the Petri dishes	9439
the OEC/ONF cultures	9439
the Petri dishes	9465
a 5-min incubation in 0.1 %	9494
a 5-min incubation	9494
0.1 %	9516
trypsin/0 .05 mM EDTA -LRB- Fluka BioChemika , Buchs , Switzerland -RRB- solution at 378C	9521
trypsin/0 .05 mM EDTA -LRB- Fluka BioChemika , Buchs , Switzerland -RRB- solution	9521
Fluka BioChemika , Buchs , Switzerland	9543
Fluka BioChemika	9543
Buchs , Switzerland	9561
378C	9593
Trypsinization	9599
culture medium	9635
a 10-min centrifugation at 1,200 rpm	9657
a 10-min centrifugation	9657
1,200 rpm	9684
the pellet	9695
culture medium	9725
OEC/ONF cultures	9741
the surface area of the PLA/PLA-b-PEO matrices -LRB- Deumens et al. , 2004 -RRB-	9777
the surface area	9777
the PLA/PLA-b-PEO matrices -LRB- Deumens et al. , 2004 -RRB-	9797
the PLA/PLA-b-PEO matrices	9797
Deumens et al. , 2004	9825
Deumens	9825
et al.	9833
2004	9841
a density of about 40,000 cells/cm2	9850
a density	9850
40,000 cells/cm2	9869
these substrates for 4 days	9899
these substrates	9899
4 days	9920
This protocol	9928
OEC/ONF-biomatrix complexes as described previously -LRB- Deumens et al. , 2004 -RRB-	9958
OEC/ONF-biomatrix complexes as described previously	9958
OEC/ONF-biomatrix complexes	9958
Deumens	10011
et al. , 2004	10019
et al.	10019
2004	10027
One day before transplantation -LRB- i.e. , DIV13 -RRB- , both the OEC	10034
One day	10034
transplantation -LRB- i.e. , DIV13 -RRB- , both the OEC	10049
transplantation	10049
i.e. , DIV13	10066
i.e.	10066
DIV13	10072
the OEC	10085
ONF cultures and the OEC/ONF-biomatrix complexes	10094
ONF cultures	10094
the OEC/ONF-biomatrix complexes	10111
Hoechst	10164
This	10173
a 40 -- 60-min incubation at 37 °C in 2 µg/ml	10190
a 40	10190
60-min incubation at 37 °C in 2 µg/ml	10195
60-min incubation	10195
37 °C in 2 µg/ml	10216
37 °C	10216
2 µg/ml	10224
Hoechst 33342 -LRB- Sigma , Uithoorn , The Netherlands -RRB- in culture medium	10232
Hoechst 33342 -LRB- Sigma , Uithoorn , The Netherlands -RRB-	10232
Hoechst 33342	10232
Sigma	10247
Uithoorn	10254
The Netherlands	10264
culture medium	10284
the OEC/ONF cultures and OEC/ONF-biomatrices	10312
culture medium	10386
Surgeries General .	10402
every operation -LRB- i.e. , SCI , transplantation , and CS tract labeling -RRB-	10425
every operation	10425
i.e. , SCI , transplantation , and CS tract labeling	10442
i.e.	10442
SCI	10448
transplantation	10453
CS tract labeling	10474
animals	10494
intraperitoneal -LRB- i.p. -RRB- injections	10511
Temgesic -LRB- 0.1 ml/animal ; Schering-Plough , Utrecht , The Netherlands -RRB-	10550
Temgesic	10550
0.1 ml/animal ; Schering-Plough	10560
0.1 ml/animal	10560
Schering-Plough	10575
Utrecht , The Netherlands	10592
Utrecht	10592
The Netherlands	10601
One hour	10619
the injection	10634
the animals	10649
a mixture of 1	10684
a mixture	10684
1	10697
2 % halothane -LRB- Abbott , Hoofddorp , The Netherlands -RRB- and O2/N2O -LRB- 1:2 -RRB-	10699
2 % halothane -LRB- Abbott , Hoofddorp , The Netherlands -RRB-	10699
2 % halothane	10699
Abbott	10713
Hoofddorp	10721
The Netherlands	10732
O2/N2O -LRB- 1:2 -RRB-	10753
O2/N2O	10753
1:2	10761
an ophthalmic ointment , Visagel -LRB- Eurovet , Bladel , The Netherlands -RRB- ,	10771
an ophthalmic ointment	10771
Visagel -LRB- Eurovet , Bladel , The Netherlands -RRB-	10795
Visagel	10795
Eurovet	10804
Bladel	10813
The Netherlands	10821
the eyes	10854
the operation	10888
the beginning of every operation	10906
the beginning	10906
every operation	10923
the hair overlying the operation area	10940
the hair	10940
the operation area	10959
the skin	10993
Betadine	11016
the end of every operation	11029
the end	11029
every operation	11040
the muscles and skin	11057
animals	11095
awake	11123
their home cages	11150
At least 1 hr	11168
their awakening	11188
the animals	11205
another i.p. injection	11226
Temgesic	11254
SCI	11264
the age of 9 weeks	11272
the age	11272
9 weeks	11283
a laminectomy	11292
T11/T12 of 16 animals	11323
T11/T12	11323
16 animals	11334
the spinal cord	11349
The dura mater	11378
the use of microscissors	11411
the use	11411
microscissors	11422
the dorsal half of the spinal cord	11436
the dorsal half	11436
the spinal cord	11455
two spinal levels	11486
2 mm	11505
an aspiration device	11526
the dorsal part of the spinal cord between the two cuts	11548
the dorsal part	11548
the spinal cord between the two cuts	11567
the spinal cord	11567
the two cuts	11591
Standardization of the lesion depth -LRB- 1.2 mm -RRB-	11617
Standardization of the lesion depth	11617
Standardization	11617
the lesion depth	11636
1.2 mm	11654
the dorsal part of the CS tract	11684
the dorsal part	11684
the CS tract	11703
a reference	11719
The dorsal CS tract	11732
the ventralmost part of the dorsal funiculus	11766
the ventralmost part	11766
the dorsal funiculus	11790
removal of the dorsal CS tract	11822
removal	11822
the dorsal CS tract	11833
the central canal and central gray matter	11854
the central canal	11854
central gray matter	11876
the center of the spinal cord	11915
the center	11915
the spinal cord	11929
this	11952
the lesion	11958
This lesion	11993
descending rubrospinal axons , the dorsal component of the CS tract , all ascending dorsal column axons , and local spinal sensory neurites	12016
descending rubrospinal axons	12016
the dorsal component of the CS tract	12046
the dorsal component	12046
the CS tract	12070
all ascending dorsal column axons	12084
all	12084
dorsal column axons	12098
local spinal sensory neurites	12123
Four weeks	12171
SCI	12188
the spinal lesion site	12193
the connective tissue that massively invaded the lesion site	12252
the connective tissue	12252
the lesion site	12297
The experimental group of eight animals	12314
The experimental group	12314
eight animals	12340
an OEC/ONF-biomatrix transplant	12363
the thoracic lesion site , which was then covered with DuraFilm	12400
the thoracic lesion site	12400
DuraFilm	12454
addition	12467
OEC/ONF suspensions -LRB- 100,000 cells/ll ; 2 ll per injection site ; one injection site/stump -RRB-	12477
OEC/ONF suspensions	12477
100,000 cells/ll ; 2 ll per injection site ; one injection site/stump	12498
100,000 cells/ll	12498
2 ll per injection site ; one injection site/stump	12516
2 ll per injection site	12516
2 ll	12516
injection site	12525
one injection site/stump	12541
the rostral and caudal cord stumps	12586
the rostral	12586
caudal cord stumps	12602
a distance of 1 mm	12624
a distance	12624
1 mm	12638
the lesion site	12648
a depth of 1.2 mm	12671
a depth	12671
1.2 mm	12682
The control group of eight animals	12690
The control group	12690
eight animals	12711
culture medium injections	12739
1 mm rostral and caudal to the lesion site to control for possible damage induced by the injection procedure	12765
1 mm	12765
rostral and caudal	12770
the lesion site	12792
possible damage induced by the injection procedure	12823
possible damage	12823
the injection procedure	12850
CS tract	12875
A dental drill	12894
burr holes	12926
both sides of the cranium overlying the sensorimotor cortices	12940
both sides	12940
the cranium overlying the sensorimotor cortices	12954
the cranium	12954
the sensorimotor cortices	12976
The anterograde neuronal tracer biotin dextran amine -LRB- BDA ; MW 10,000 ; Molecular Probes/Invitrogen -RRB-	13003
The anterograde neuronal tracer biotin dextran amine	13003
BDA	13057
MW 10,000 ; Molecular Probes/Invitrogen	13062
MW 10,000	13062
Molecular Probes/Invitrogen	13073
the sensorimotor cortex	13127
a depth of 2 mm	13154
a depth	13154
2 mm	13165
the cortical surface on both sides	13175
the cortical surface	13175
both sides	13199
10 %	13211
0.1 M	13218
phosphate-buffered saline -LRB- PBS -RRB- , pH 7.2 ; 1.5 ll/three injections/hemisphere -RSB-	13224
phosphate-buffered saline	13224
PBS	13251
pH 7.2 ; 1.5 ll/three injections/hemisphere -RSB-	13257
pH 7.2	13257
1.5 ll/three injections/hemisphere -RSB-	13265
The needle	13302
place for 1 min	13325
place	13325
1 min	13335
Histology	13375
16 weeks	13388
SCI	13403
the rats	13408
an overdose of Nembutal -LRB- 30 mg/kg body weight ; i.p. injection -RRB-	13426
an overdose	13426
Nembutal -LRB- 30 mg/kg body weight ; i.p. injection -RRB-	13441
Nembutal	13441
30 mg/kg body weight	13451
injection	13478
They	13490
ice-cold 4 % paraformaldehyde in 0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13529
ice-cold 4 % paraformaldehyde	13529
0.1 M phosphate buffer -LRB- pH 7.4 -RRB-	13561
0.1 M phosphate buffer	13561
pH 7.4	13585
perfusion	13600
the spinal cords and the brains	13611
the spinal cords	13611
the brains	13632
cold 4 % buffered paraformaldehyde overnight	13673
cold	13673
paraformaldehyde overnight	13690
the following day	13721
the tissue	13740
10 % sucrose in PBS -LRB- 0.1 M , pH 7.6 -RRB-	13770
10 % sucrose	13770
PBS -LRB- 0.1 M , pH 7.6 -RRB-	13785
PBS	13785
0.1 M	13790
pH 7.6	13797
overnight	13814
48C	13827
the tissue	13838
25 % sucrose in PBS	13869
25 % sucrose	13869
PBS	13884
3 days	13901
48C	13911
The brain and 2.5-cm-long spinal cord pieces including the lesion site	13916
The brain and 2.5-cm-long spinal cord pieces	13916
the lesion site	13971
808C	14014
a cryostat	14025
the spinal cord pieces	14037
sagittal sections of 25 lm	14079
sagittal sections	14079
25 lm	14100
this way	14111
about 120 sections	14121
120 sections	14127
spinal cord	14158
The sections	14171
gelatin chrome-alumn -LRB- Sigma -RRB- - coated glass slides	14212
gelatin chrome-alumn	14212
Sigma	14234
coated glass slides	14241
20 °C	14276
Alternate sections	14282
immunohistochemistry with the following antibodies : rabbit anti-GFAP -LRB- 1:1,000 ; Dako -RRB- and rabbit anti-GAP43 / B50 -LRB- 1:2,000 ; generous gift from Leo van Halewijn , Utrecht University , The Netherlands -RRB-	14320
immunohistochemistry with the following antibodies	14320
immunohistochemistry	14320
the following antibodies	14346
rabbit anti-GFAP -LRB- 1:1,000 ; Dako -RRB- and rabbit anti-GAP43 / B50 -LRB- 1:2,000 ; generous gift from Leo van Halewijn , Utrecht University , The Netherlands -RRB-	14372
rabbit anti-GFAP -LRB- 1:1,000 ; Dako -RRB-	14372
rabbit anti-GFAP	14372
1:1,000 ; Dako	14390
1:1,000	14390
Dako	14399
rabbit anti-GAP43 / B50 -LRB- 1:2,000 ; generous gift from Leo van Halewijn , Utrecht University , The Netherlands -RRB-	14409
rabbit anti-GAP43 / B50	14409
rabbit anti-GAP43	14409
B50	14427
1:2,000 ; generous gift from Leo van Halewijn	14432
1:2,000	14432
generous gift from Leo van Halewijn	14441
generous gift	14441
Leo van Halewijn	14460
Utrecht University , The Netherlands	14478
Utrecht University	14478
The Netherlands	14498
Secondary antibodies used	14516
Secondary antibodies	14516
streptavidin-Cy3 -LRB- 1:2,000 ; for the BDA-labeled CS axons ; Jackson Immunoresearch Europe Ltd. , Cambridgeshire , United Kingdom -RRB- and Alexa 488-conjugated goat anti-rabbit -LRB- 1:100 ; Molecular Probes/Invitrogen -RRB-	14547
streptavidin-Cy3 -LRB- 1:2,000 ; for the BDA-labeled CS axons ; Jackson Immunoresearch Europe Ltd. , Cambridgeshire , United Kingdom -RRB-	14547
streptavidin-Cy3	14547
1:2,000 ; for the BDA-labeled CS axons ; Jackson Immunoresearch Europe Ltd. , Cambridgeshire , United Kingdom	14565
1:2,000	14565
the BDA-labeled CS axons	14578
Jackson Immunoresearch Europe Ltd. , Cambridgeshire , United Kingdom	14604
Jackson Immunoresearch Europe Ltd.	14604
Cambridgeshire , United Kingdom	14640
Alexa 488-conjugated goat anti-rabbit -LRB- 1:100 ; Molecular Probes/Invitrogen -RRB-	14676
Alexa	14676
488-conjugated goat anti-rabbit -LRB- 1:100 ; Molecular Probes/Invitrogen -RRB-	14682
488-conjugated goat anti-rabbit	14682
1:100 ; Molecular Probes/Invitrogen	14715
1:100	14715
Molecular Probes/Invitrogen	14722
Antibodies	14752
0.3 % Triton X-100 in Tris-buffered saline -LRB- TBS-T -RRB-	14779
0.3 % Triton X-100	14779
Tris-buffered saline -LRB- TBS-T -RRB-	14800
Tris-buffered saline	14800
TBS-T	14822
Primary antibody incubations	14830
overnight at room temperature	14864
overnight	14864
room temperature	14877
Scondary antibody incubations	14895
1.5 hr at room temperature	14934
1.5 hr	14934
room temperature	14944
double-staining protocols	14965
the primary antibodies	14992
a mixture	15028
the incubation with the Cy-3-labeled secondary antibody	15043
the incubation	15043
the Cy-3-labeled secondary antibody	15063
the incubation	15115
the Alexa-labeled secondary antibody	15135
all antibody incubations	15180
the washing steps	15206
10 min TBS-T , 10 min TBS -LRB- TBS-T without Triton X-100 -RRB- , and 10 min TBST	15237
10 min TBS-T	15237
10 min TBS	15251
TBS-T without Triton X-100	15263
TBS-T	15263
Triton X-100	15277
10 min TBST	15296
All other washing steps	15309
All other	15309
steps	15327
3 3	15342
10 min	15346
TBS	15356
Every sixth section	15361
GFAP/BDA labeled CS axons or GAP43/BDA labeled CS axons	15404
GFAP/BDA	15404
CS axons or GAP43/BDA labeled CS axons	15421
CS axons	15421
GAP43/BDA labeled CS axons	15433
GAP43/BDA	15433
CS axons	15451
Stained sections	15461
an Olympus AX-70 microscope and epifluorescent illumination	15497
The microscope	15558
a 320 objective and a 310 projection lens	15591
a 320 objective	15591
a 310 projection lens	15611
The signal for Alexa 488 -LRB- green -RRB-	15634
The signal for Alexa 488	15634
The signal	15634
Alexa 488	15649
a narrow-band MNIBA-type FITC filter -LRB- Chroma Technology Corp , Rockingham , VT -RRB-	15689
a narrow-band MNIBA-type FITC filter	15689
Chroma Technology Corp	15727
Rockingham	15751
VT	15763
the signal for Cy3 -LRB- red -RRB-	15768
the signal	15768
Cy3 -LRB- red -RRB-	15783
Cy3	15783
red	15788
an MNG filter -LRB- Chroma Technology Corp. -RRB-	15815
an MNG filter	15815
Chroma Technology Corp.	15830
the signal for Hoechst -LRB- blue -RRB-	15860
the signal for Hoechst	15860
the signal	15860
Hoechst	15875
a U-MNIBA filter -LRB- Chroma Technology Corp. -RRB-	15912
a U-MNIBA filter	15912
Chroma Technology Corp.	15930
Pictures of the stained sections were made at a magnification of 320 with a Sony Power HAD 3CCD Color Video Camera or an Olympus F-view	15956
Pictures	15956
the stained sections were made at a magnification of 320 with a Sony Power HAD 3CCD Color Video Camera or an Olympus F-view	15968
the	15968
sections	15980
a magnification of 320	16002
a magnification	16002
320	16021
a Sony Power HAD 3CCD Color Video Camera or an Olympus F-view	16030
a Sony Power HAD 3CCD Color Video Camera	16030
an Olympus F-view	16074
CCD camera -LRB- Paes , Zoeterwoude , The Netherlands -RRB-	16099
CCD camera	16099
Paes	16111
Zoeterwoude	16117
The Netherlands	16130
All pictures	16148
the image analyzing system analySIS 3.0	16180
the image	16180
system analySIS 3.0	16200
-LRB- Soft Imaging System , Mu ¨ nster , Germany -RRB- .	16221
Soft	16222
System , Mu	16235
System	16235
Mu	16243
¨ nster , Germany	16245
¨ nster	16245
Germany	16253
Quantitative Analysis of CS Axons All sections with BDA-labeled CS axons	16263
Quantitative Analysis	16263
CS Axons All sections with BDA-labeled CS axons	16288
CS Axons All sections	16288
BDA-labeled CS axons	16315
quantitative analysis	16355
250-µm-wide boxes	16378
four different locations in the spinal cord sections	16411
four different locations	16411
the spinal cord sections	16439
The first box	16465
the dorsal gray/white matter at 2.5 -- 3.0 mm rostral to the injury site	16493
the dorsal gray/white matter at 2.5	16493
the dorsal gray/white matter	16493
2.5	16525
3.0 mm rostral to the injury site	16529
3.0 mm rostral	16529
the injury site	16547
the rostral reference	16582
The second box	16605
the dorsal gray/white matter directly rostral	16634
the dorsal gray/white matter	16634
the injury site	16683
The third box	16700
the gray matter	16728
the lesion site	16752
only few axons	16777
the lesion site	16816
the box	16833
the area where most BDA immunoreactivity was found	16855
the area	16855
most BDA immunoreactivity	16870
The fourth box	16907
the gray matter caudal	16936
the injury site	16962
the position where most BDA immunoreactivity could be found	16988
the position	16988
most BDA immunoreactivity	17007
The few BDA-immunoreactive CS axons	17049
the caudal gray matter within 10 mm	17117
the caudal gray matter	17117
10 mm	17147
the caudal edge of the lesion site	17158
the caudal edge	17158
the lesion site	17177
All four boxes	17194
all the sections containing BDA-labeled CS axons	17226
all the sections	17226
BDA-labeled CS axons	17254
The percentage of each box occupied by BDA-immunoreactive axons -LRB- `` BDA immunoreactivity occupation '' -RRB-	17276
The percentage	17276
each box occupied by BDA-immunoreactive axons -LRB- `` BDA immunoreactivity occupation '' -RRB-	17294
each box	17294
BDA-immunoreactive axons -LRB- `` BDA immunoreactivity occupation '' -RRB-	17315
BDA-immunoreactive axons	17315
BDA	17343
immunoreactivity occupation ''	17347
immunoreactivity	17347
occupation ''	17364
the box values in all the sections	17396
the box values	17396
all the sections	17414
the efficiency of BDA CS tract tracing	17452
the efficiency	17452
BDA CS tract tracing	17470
BDA CS tract	17470
animals	17517
the BDA immunoreactivity at the rostral reference	17526
the BDA immunoreactivity	17526
the rostral reference	17554
the 100 % reference value of BDA-labeled axons of each animal	17589
the 100 % reference value	17589
BDA-labeled axons of each animal	17617
BDA-labeled axons	17617
each animal	17638
The BDA immunoreactivity values of boxes 2 , 3 , and 4	17651
The BDA immunoreactivity values	17651
boxes 2 , 3 , and 4	17686
boxes	17686
2 , 3 , and 4	17692
that of the rostral reference	17731
that	17731
the rostral reference	17739
A similar quantification method	17762
others -LRB- Goldshmit et al. , 2004 -RRB-	17827
others	17827
Goldshmit	17835
et al. , 2004	17845
et al.	17845
2004	17853
Functional Testing Basso Beattie Bresnahan -LRB- BBB -RRB- locomotor rating scale .	17860
Functional	17860
Basso Beattie Bresnahan -LRB- BBB -RRB-	17879
Basso Beattie Bresnahan	17879
BBB	17904
locomotor rating scale	17909
This locomotor test	17933
locomotor performance of the hind limbs	17962
locomotor performance	17962
the hind limbs	17987
a score that ranges from 0 to 21 -LRB- Basso et al. , 1995 -RRB-	18026
a score	18026
0 to 21	18051
Basso	18060
et al. , 1995	18066
et al.	18066
1995	18074
The scores of the left and right hind limbs	18081
The scores	18081
the left and right hind limbs	18095
the BBB score of the animal	18152
the BBB score	18152
the animal	18169
The BBB test	18181
the day of the operation	18226
the day	18226
the operation	18237
the following days postoperatively -LRB- DPO -RRB- : 1 , 2 , 3 , 7 , and weekly	18258
the following days postoperatively -LRB- DPO -RRB-	18258
the following days postoperatively	18258
the following days	18258
DPO	18294
1 , 2 , 3 , 7 , and weekly	18300
1	18300
2	18303
3	18306
7	18309
weekly	18316
CatWalk gait analysis .	18335
CatWalk	18335
gait analysis	18343
This locomotor test	18358
an easy and objective analysis of both static and dynamic locomotor parameters , such as stride length , base of support , interlimb coordination , and swing/stance phases	18385
an easy and objective analysis	18385
both static and dynamic locomotor parameters	18419
stride length , base of support , interlimb coordination , and swing/stance phases	18473
stride length	18473
base of support	18488
base	18488
support	18496
interlimb coordination	18505
swing/stance phases	18533
Details on the CatWalk set-up	18554
Details	18554
the CatWalk set-up	18565
Hamers et al. , 2001 ; Koopmans et al. , 2005	18608
Hamers	18608
et al. , 2001 ; Koopmans et al. , 2005	18615
et al. , 2001	18615
et al.	18615
2001	18623
Koopmans et al. , 2005	18629
Koopmans	18629
et al. , 2005	18638
et al.	18638
2005	18646
a training period of 2 weeks	18662
a training period	18662
2 weeks	18683
animals	18704
a glass runway	18721
hesitation	18744
this training period	18763
the animals	18785
a 12 g/day food-restriction protocol	18816
24 hr before postoperative testing	18857
24 hr	18857
postoperative testing	18870
the animals	18893
food	18922
Small food pellets	18928
Noyes Precision	18948
PJPPP-0045 ; Sandown Chemical Ltd. , Hampton , United Kingdom	18972
PJPPP-0045	18972
Sandown Chemical Ltd. , Hampton , United Kingdom	18984
located at the end of the glass runway	19032
the end of the glass	19043
the end	19043
the glass	19054
a reward	19084
analysis	19098
three uninterrupted runs	19108
CatWalk-based BBB scale .	19144
CatWalk-based BBB	19144
scale	19162
Forelimb-hindlimb coordination	19169
an extremely important aspect in the BBB score	19203
an extremely important aspect	19203
the BBB score	19236
the assessment of such coordination via the BBB locomotor rating scale	19260
the assessment	19260
such coordination via the BBB locomotor rating scale	19278
such coordination	19278
the BBB locomotor rating scale	19300
Correct assessment of locomotor performance	19353
Correct assessment	19353
locomotor performance	19375
correct assessment of coordination	19406
correct assessment	19406
coordination	19428
this end	19445
we	19455
a method in which the objective parameter for coordination , the regularity index -LRB- RI -RRB- , obtained from the CatWalk analysis is implemented in the BBB scoring -LRB- Koopmans et al. , 2005 -RRB-	19484
a method	19484
the objective parameter for coordination , the regularity index -LRB- RI -RRB- , obtained from the CatWalk analysis	19502
the objective parameter	19502
coordination , the regularity index -LRB- RI -RRB- , obtained from the CatWalk analysis	19530
coordination	19530
the regularity index -LRB- RI -RRB-	19544
the regularity index	19544
RI	19566
the CatWalk analysis	19585
the BBB	19624
scoring -LRB- Koopmans et al. , 2005 -RRB-	19632
scoring	19632
Koopmans	19641
et al. , 2005	19650
et al.	19650
2005	19658
brief	19668
the RI grades the degree of coordination as the number of normal step sequence patterns	19675
the RI	19675
grades	19682
the degree of coordination as the number of normal step sequence patterns	19689
the degree	19689
coordination as the number of normal step sequence patterns	19703
coordination	19703
the number of normal step sequence patterns	19719
the number	19719
normal step sequence patterns	19733
four	19777
the total number of paw placements	19794
the total number	19794
paw placements	19814
100 %	19847
Crossings of the glass runway with a RI of 100 %	19853
Crossings	19853
the glass runway with a RI of 100 %	19866
the glass runway	19866
a RI of 100 %	19888
a RI	19888
100 %	19896
three , two , one , or none of the CatWalk runs	19932
three	19932
two	19939
one	19944
none of the CatWalk runs	19952
none	19952
the CatWalk runs	19960
no coordination	20031
the BBB score of the animal at that testing day	20072
the BBB score	20072
the animal at that testing day	20089
the animal	20089
that testing day	20103
RESULTS Figure 1 .	20136
RESULTS	20136
Figure 1	20144
Neuropathological effects of the multifactorial transplantation strategy .	20154
Neuropathological effects	20154
the multifactorial transplantation strategy	20183
Corticospinal -LRB- CS -RRB- axons , injured by a low-thoracic dorsal hemisection injury ,	20228
Corticospinal -LRB- CS -RRB- axons	20228
a low-thoracic dorsal hemisection injury	20265
the anterograde tracer BDA	20325
These axons	20353
an unbranched course at 2.5 -- 3 mm rostral to the lesion gap -LRB- A -RRB-	20386
an unbranched course at 2.5	20386
an unbranched course	20386
2.5	20410
3 mm rostral to the lesion gap -LRB- A -RRB-	20414
3 mm rostral	20414
the lesion gap -LRB- A -RRB-	20430
the lesion gap	20430
A	20446
a sproutinglike morphology directly rostral to the lesion gap -LRB- B -RRB-	20463
a sproutinglike morphology	20463
the lesion gap	20510
B	20526
Quantitative analysis using four boxes as indicated in C	20530
Quantitative analysis	20530
four boxes	20558
indicated in C	20572
indicated	20572
C	20585
BDA immunoreactivity	20599
rostral	20650
the injury site in transplanted vs. control animals -LRB- D -RRB-	20661
the injury site	20661
transplanted vs. control animals -LRB- D -RRB-	20680
transplanted	20680
control animals -LRB- D -RRB-	20697
control animals	20697
D	20714
E : These rostral CS axons -LRB- some indicated with arrowheads -RRB- were not GAP43/B50 immunoreactive -LRB- BDA in red , GAP43/B50 in green -RRB- ;	20718
E	20718
These rostral CS axons -LRB- some indicated with arrowheads -RRB- were not GAP43/B50 immunoreactive -LRB- BDA in red , GAP43/B50 in green -RRB-	20721
These rostral CS	20721
axons -LRB- some indicated with arrowheads -RRB-	20738
axons	20738
some indicated with arrowheads	20745
some	20745
arrowheads	20765
GAP43/B50 immunoreactive -LRB- BDA in red , GAP43/B50 in green -RRB-	20786
GAP43/B50	20786
BDA in red , GAP43/B50 in green	20812
BDA	20812
red , GAP43/B50 in green	20819
red	20819
GAP43/B50 in green	20824
GAP43/B50	20824
the GAP43/B50 immunoreactive fiber -LRB- arrow -RRB-	20850
the GAP43/B50 immunoreactive fiber	20850
arrow	20886
The transplanted OEC/ONF-biomatrix within the lesion gap	20894
The transplanted OEC/ONF-biomatrix	20894
the lesion gap	20936
GAP43/B50-immunoreactive fibers -LRB- F -RRB-	20969
GAP43/B50-immunoreactive fibers	20969
F	21002
P < 0.01 .	21008
P	21008
< 0.01 .	21010
<	21010
0.01 .	21012
Figure 2 .	21019
Figure	21019
2	21026
Outcome of multifactorial transplantation strategy on gross locomotor function .	21029
Outcome	21029
multifactorial transplantation strategy	21040
gross locomotor function	21083
A	21109
Both	21112
-LRB- OEC/ONF -RRB- and control animals	21130
-LRB- OEC/ONF -RRB-	21130
control animals	21144
the BBB locomotor rating scale	21184
an initial drop in the BBB scale	21222
an initial drop	21222
the BBB scale	21241
all animals	21256
a plateau level of about BBB score 11 after the first postoperative week	21281
a plateau level	21281
BBB	21306
11	21316
the first postoperative week	21325
a slight drop in the BBB	21366
a slight drop	21366
the BBB	21383
the second operation -LRB- transplantation -RRB- at DPO28 , both animal groups	21406
the second operation -LRB- transplantation -RRB-	21406
the second operation	21406
transplantation	21428
DPO28 , both animal groups	21448
DPO28	21448
animal groups	21460
this postoperative plateau	21486
B : Implementation of the CatWalk-derived regularity index -LRB- RI -RRB- into the BBB	21514
B : Implementation of the CatWalk-derived regularity index	21514
B	21514
Implementation of the CatWalk-derived regularity index	21517
Implementation	21517
the CatWalk-derived regularity index	21535
RI	21573
the BBB	21582
the BBB scores	21609
no intergroup differences	21640
line	21688
the time of transplantation ; DPO , postoperative days	21704
the time of transplantation	21704
the time	21704
transplantation	21716
DPO , postoperative days	21733
DPO	21733
postoperative days	21738
Figure 3 .	21759
Figure	21759
3	21766
Outcome of multifactorial transplantation strategy on fine locomotor function .	21769
Outcome	21769
multifactorial transplantation strategy	21780
fine locomotor function	21823
Three parameters reflecting fine locomotor functions as assessed with the CatWalk gait analysis	21848
Three parameters	21848
fine locomotor functions	21876
the CatWalk gait analysis	21918
The base of support -LRB- BOS -RRB- of the hind limbs	21959
The base	21959
support -LRB- BOS -RRB- of the hind limbs	21971
support -LRB- BOS -RRB-	21971
support	21971
BOS	21980
the hind limbs	21988
SCI -LRB- A -RRB-	22019
SCI	22019
A	22024
Our transplantation strategy	22028
any recovery of this parameter	22075
any recovery	22075
this parameter	22091
Both	22107
speed and stride length of the hind limbs -LRB- B , C -RRB-	22118
speed and stride length	22118
the hind limbs -LRB- B , C -RRB-	22145
the hind limbs	22145
B , C	22161
B	22161
C	22163
the SCI	22189
line	22205
the time of transplantation	22221
the time	22221
transplantation	22233
DPO	22250
all 16 animals	22279
a significant drop	22301
the BBB score	22323
postoperative time points	22340
the BBB score of all animals	22367
the BBB score	22367
all animals	22384
11 at DPO28 -LRB- the day of transplantation -RRB-	22400
11	22400
DPO28 -LRB- the day of transplantation -RRB-	22406
DPO28	22406
the day of transplantation	22413
the day	22413
transplantation	22424
This	22442
line with previous work -LRB- Joosten et al. , 2004 -RRB-	22454
line	22454
previous work -LRB- Joosten et al. , 2004 -RRB-	22464
previous work	22464
Joosten	22479
et al. , 2004	22487
et al.	22487
2004	22495
animals within these limits	22516
animals	22516
these limits	22531
1 -RRB- received a correct and standardized dorsal hemisection injury and 2	22544
1 -RRB- received a correct and standardized dorsal hemisection injury	22544
the CatWalk analysis at DPO28	22631
the CatWalk analysis	22631
DPO28	22655
These animals	22662
two groups , a group subjected to a multifactorial OEC / ONF transplantation strategy and a control group	22715
two groups	22715
a group subjected to a multifactorial OEC / ONF transplantation strategy and a control group	22727
a group	22727
a multifactorial OEC / ONF transplantation strategy and a control group	22748
a multifactorial OEC	22748
ONF transplantation strategy and a control group	22770
ONF transplantation strategy	22770
a control group	22803
Two control animals	22820
a BBB score	22844
11 at the last time point -LRB- DPO112 -RRB- , making them unsuitable	22862
11	22862
the last time point -LRB- DPO112 -RRB-	22868
the last time point	22868
DPO112	22889
them	22905
CatWalk analysis	22925
the study	22976
addition	22990
two transplanted animals	23003
no Hoechst-prelabeled cells	23029
these two animals	23096
the study	23133
the transplanted group	23151
eight animals ; the control group of six	23187
eight animals	23187
the control group of six	23202
the control group	23202
six	23223
The OEC/ONF culturing	23228
initial culturing techniques developed by Ramon-Cueto and coworkers -LRB- 1992 -RRB- , but slightly adjusted -LRB- Li et al. , 1998 -RRB-	23262
initial culturing techniques developed by Ramon-Cueto and coworkers -LRB- 1992 -RRB- , but slightly adjusted	23262
initial culturing techniques developed by Ramon-Cueto and coworkers -LRB- 1992 -RRB-	23262
initial culturing techniques	23262
Ramon-Cueto and coworkers -LRB- 1992 -RRB-	23304
Ramon-Cueto	23304
coworkers -LRB- 1992 -RRB-	23320
coworkers	23320
1992	23331
Li	23361
et al. , 1998	23364
et al.	23364
1998	23372
Two main cell populations	23379
these cultures : the so-called OEC and ONF -LRB- Li et al. , 1998 -RRB-	23424
these cultures	23424
the so-called OEC and ONF	23440
Li	23467
et al. , 1998	23470
et al.	23470
1998	23478
The OEC population	23485
spindle-shaped cells , immunoreactive for the p75-NGF receptor , S100b , and glial fibrillary acidic protein -LRB- GFAP ; Franceschini and Barnett , 1996 ; Deumens et al. , 2004 -RRB-	23530
spindle-shaped cells	23530
the p75-NGF receptor	23571
S100b	23593
glial fibrillary acidic protein -LRB- GFAP ; Franceschini and Barnett , 1996 ; Deumens et al. , 2004 -RRB-	23604
glial fibrillary acidic protein	23604
GFAP ; Franceschini and Barnett , 1996 ; Deumens et al. , 2004	23637
GFAP	23637
Franceschini and Barnett , 1996 ; Deumens et al. , 2004	23643
Franceschini and Barnett , 1996	23643
Franceschini and Barnett	23643
1996	23669
Deumens et al. , 2004	23675
Deumens	23675
et al. , 2004	23683
et al.	23683
2004	23691
The ONF population	23698
fibroblast-like cells , immunoreactive for proteins such as fibronectin and GFAP -LRB- Li et al. , 1998 ; Deumens et al. , 2004 -RRB-	23738
fibroblast-like cells	23738
proteins such as fibronectin and GFAP -LRB- Li et al. , 1998 ; Deumens et al. , 2004 -RRB-	23780
proteins	23780
fibronectin and GFAP -LRB- Li et al. , 1998 ; Deumens et al. , 2004 -RRB-	23797
fibronectin and GFAP	23797
Li	23819
et al. , 1998 ; Deumens et al. , 2004	23822
et al.	23822
1998 ; Deumens et al.	23830
1998	23830
Deumens et al.	23836
Deumens	23836
et al.	23844
2004	23852
These OEC/ONF	23859
poly -LRB- D , L -RRB- - lactide matrices	23898
poly -LRB- D , L -RRB-	23898
poly	23898
lactide matrices	23908
Deumens et al. , 2004	23926
Deumens	23926
et al.	23934
2004	23942
Petri dishes	23959
Hoechst	24007
transplantation	24022
the injured spinal cord as detectable by a clear blue nuclear staining of these cells	24043
the injured spinal cord	24043
detectable by a clear blue nuclear staining of these cells	24070
a clear blue nuclear staining of these	24084
a clear blue nuclear staining	24084
these	24117
six of eight animals	24142
six	24142
eight animals	24149
the OEC/ONF injections into the injured spinal cord	24164
the OEC/ONF injections	24164
the injured spinal cord	24192
a clearly blue Hoechst staining within the putative injection areas rostral and caudal	24247
a clearly blue Hoechst staining	24247
the putative injection areas rostral and caudal	24286
the putative injection areas	24286
the injury site	24337
DPO112	24356
the OEC/ONF-biomatrix complex within the lesion gap	24376
the OEC/ONF-biomatrix complex	24376
the lesion gap	24413
prelabeled Hoechst-positive OEC/ONF	24453
a single transplanted animal	24493
a thin rim of Hoechst-positive cells	24523
a thin rim	24523
Hoechst-positive cells	24537
the OEC	24581
ONF-biomatrix complex and the host	24590
ONF-biomatrix complex	24590
the host	24616
spinal cord tissue	24625
The CS tract labeling	24645
all transplanted animals	24685
all control animals but one	24717
all control animals	24717
one	24741
analysis of CS tract regrowth	24753
analysis	24753
CS tract regrowth	24765
six transplanted and five control animals	24800
six transplanted	24800
five control animals	24821
saggital sections of these animals	24846
saggital sections	24846
these animals	24867
the BDA-labeled CS axons	24882
the border between the dorsal gray and white	24932
the border	24932
the dorsal gray and white	24951
the dorsal	24951
a distance of 2.5 -- 3 cm rostral from the injury site	24988
a distance of 2.5	24988
a distance	24988
2.5	25002
3 cm rostral from the injury site	25006
3 cm rostral	25006
the injury site	25024
the BDA-labeled CS axons	25041
an uninterrupted , unbranched course	25075
few instances innervating the underlying gray matter -LRB- Fig. 1A -RRB-	25115
few instances	25115
the underlying gray matter -LRB- Fig. 1A -RRB-	25141
the underlying gray matter	25141
Fig. 1A	25169
Closer to the injury site , these BDA-labeled CS axons	25179
the injury site , these BDA-labeled CS	25189
the injury site	25189
these BDA-labeled CS	25206
a strongly interrupted , branched course , with apparent sprouting -LRB- Fig. 1B -RRB-	25242
a strongly interrupted	25242
branched course	25266
apparent sprouting -LRB- Fig. 1B -RRB-	25288
apparent sprouting	25288
Fig. 1B	25308
all animals	25321
the majority of BDA-labeled CS axons	25334
the majority	25334
BDA-labeled CS axons	25350
the lesion site	25382
none	25437
the graft/lesion site	25447
only a small minority	25473
the graft/lesion site	25503
the caudal host tissue	25534
The effect of the multifactorial transplantation intervention on regrowth of injured BDA-labeled CS axons	25558
The effect	25558
the multifactorial transplantation intervention on regrowth of injured BDA-labeled CS axons	25572
the multifactorial transplantation intervention	25572
regrowth of injured BDA-labeled CS axons	25623
regrowth	25623
injured BDA-labeled CS axons	25635
four boxes in the saggital spinal cord sections -LRB- Fig. 1C -RRB-	25701
four boxes	25701
the saggital spinal cord sections -LRB- Fig. 1C -RRB-	25715
the saggital spinal cord sections	25715
Fig. 1C	25750
There	25760
a strong variation in the labeling efficiency of the CS tract	25770
a strong variation	25770
the labeling efficiency of the CS tract	25792
the labeling efficiency	25792
the CS tract	25819
the rostral reference	25836
the BDA immunoreactivity occupation	25859
10.1 % 6 5.5 % and 11.3 % 6 2.6 %	25899
10.1 % 6 5.5 % and 11.3 %	25899
transplanted and control animals , respectively -LRB- n.s. -RRB-	25932
transplanted	25932
control animals , respectively -LRB- n.s. -RRB-	25949
control animals , respectively	25949
control animals	25949
n.s.	25980
These values	25987
the 100 % value of labeled CS axons	26012
the 100 % value	26012
labeled CS axons	26030
rostral to the injury site , the BDA immunoreactivity occupation in control animals	26057
rostral	26057
the injury site , the BDA immunoreactivity occupation in control animals	26068
the injury site	26068
the BDA immunoreactivity occupation in control animals	26085
the BDA immunoreactivity occupation	26085
control animals	26124
100 % to 33.2 % 6 6.0 % -LRB- Fig. 1D -RRB-	26165
100 % to 33.2 % 6 6.0 %	26165
100 % to 33.2 %	26165
6 6.0 %	26179
Fig. 1D	26187
animals that were subjected to the multifactorial transplantation at 4 weeks after injury	26206
animals	26206
the multifactorial transplantation at 4 weeks	26237
the multifactorial transplantation	26237
4 weeks	26275
injury	26289
a modest increase	26303
the BDA immunoreactivity occupation at this rostral location	26324
the BDA immunoreactivity occupation	26324
this rostral location	26363
100 % to 124.1 % 6 22.1 % -LRB- Fig. 1D -RRB-	26390
100 % to 124.1 % 6 22.1 %	26390
100 % to 124.1 %	26390
Fig. 1D	26414
Quantitative analysis	26424
a significant difference between BDA	26458
a significant difference	26458
BDA	26491
immunoreactivity occupation of transplanted and control animals directly rostral to the lesion gap -LRB- two-tailed t-test , P < 0.01 -RRB-	26495
immunoreactivity occupation	26495
transplanted and control animals directly rostral to the lesion gap -LRB- two-tailed t-test , P < 0.01 -RRB-	26526
transplanted and control animals	26526
the lesion gap -LRB- two-tailed t-test , P < 0.01 -RRB-	26579
the lesion gap	26579
two-tailed t-test , P	26595
< 0.01	26616
<	26616
0.01	26618
The greatest BDA immunoreactivity beneath the lesion/graft and caudal to the injury site	26625
The greatest BDA immunoreactivity	26625
the lesion/graft and caudal to the injury site	26667
the lesion/graft and caudal	26667
the injury site	26698
the two animal groups -LRB- n.s. -RRB-	26737
the two animal groups	26737
n.s.	26760
Further investigation of the CS axon regrowth response	26767
Further investigation	26767
the CS axon regrowth response	26792
the injured BDA-labeled CS axons	26834
the injury site	26887
the GAP43/B50	26919
protein -LRB- Fig. 1E -RRB-	26933
protein	26933
Fig. 1E	26942
The validity of the GAP43/B50 staining	26952
The validity	26952
the GAP43/B50 staining	26968
the observation of numerous GAP43-positive axons	27007
the observation	27007
numerous GAP43-positive axons	27026
the CST	27074
the OEC/ONF-biomatrix complex of transplanted animals -LRB- Fig. 1F -RRB-	27096
the OEC/ONF-biomatrix complex	27096
transplanted animals -LRB- Fig. 1F -RRB-	27129
transplanted animals	27129
Fig. 1F	27151
the behavioral analysis	27164
12 animals	27189
six that were successfully transplanted and six control animals	27215
six	27215
transplanted and six control animals	27242
transplanted	27242
six control animals	27259
Gross locomotor analysis using the BBB locomotor rating scale	27280
Gross locomotor analysis	27280
the BBB locomotor rating scale	27311
a significant drop	27349
the BBB score	27371
all animals at DPO1 -LRB- Fig. 2A -RRB-	27389
all animals	27389
DPO1 -LRB- Fig. 2A -RRB-	27404
DPO1	27404
Fig. 2A	27410
the first week	27427
the BBB score	27443
a plateau level of BBB score 11	27480
a plateau level	27480
BBB score 11	27499
BBB	27499
11	27509
This score	27513
the day of transplantation -LRB- DPO28 -RRB-	27545
the day	27545
transplantation -LRB- DPO28 -RRB-	27556
transplantation	27556
DPO28	27573
Fine locomotor analysis , using the CatWalk gait analysis ,	27581
Fine locomotor analysis	27581
the CatWalk gait analysis	27612
very limited behavioral impairment	27646
a result of the SCI	27684
a result	27684
the SCI	27696
an increased base of support of the hind limbs -LRB- Fig. 3A -RRB-	27715
an increased base	27715
support of the hind limbs -LRB- Fig. 3A -RRB-	27736
support	27736
the hind limbs -LRB- Fig. 3A -RRB-	27747
the hind limbs	27747
Fig. 3A	27763
No impairments in fine locomotor parameters , such as swing speed ,	27773
No impairments	27773
fine locomotor parameters	27791
swing speed	27826
duration , or stride length of the hindlimbs ,	27845
duration	27845
stride length of the hindlimbs	27858
stride length	27858
the hindlimbs	27875
injury -LRB- Fig. 3B , C -RRB-	27910
injury	27910
Fig. 3B , C	27918
Fig. 3B	27918
C	27926
the second operation at DPO28 -LRB- transplantation or sham operation -RRB-	27948
the second operation	27948
DPO28 -LRB- transplantation or sham operation -RRB-	27972
DPO28	27972
transplantation or sham operation	27979
there	28015
a slight drop in the BBB score of both animal groups -LRB- Fig. 2A -RRB-	28025
a slight drop	28025
the BBB score of both animal groups -LRB- Fig. 2A -RRB-	28042
the BBB score	28042
both animal groups -LRB- Fig. 2A -RRB-	28059
both animal groups	28059
Fig. 2A	28079
the scores	28093
the pretransplantation plateau BBB level of 11	28125
the pretransplantation plateau BBB level	28125
11	28169
the entire postoperative period	28184
no significant differences	28217
OEC/ONF-transplanted and control animals	28266
Implementation of the more sensitive and objective measure for coordination , the regularity index -LRB- RI -RRB- , into the BBB score	28308
Implementation	28308
the more sensitive and objective measure for coordination , the regularity index -LRB- RI -RRB- , into the BBB score	28326
the more sensitive and objective measure	28326
coordination , the regularity index -LRB- RI -RRB- ,	28371
coordination	28371
the regularity index -LRB- RI -RRB-	28385
the regularity index	28385
RI	28407
the BBB score	28417
intergroup differences	28449
the BBB score	28481
a similar extent in both the transplanted and the control groups -LRB- Fig. 2B -RRB-	28512
a similar extent in both the transplanted	28512
a similar extent	28512
the transplanted	28537
the control groups -LRB- Fig. 2B -RRB-	28558
the control groups	28558
Fig. 2B	28578
No signifi	28588
cant differences	28600
CatWalk locomotor parameters between OEC/ONF-transplanted and control animals	28634
CatWalk locomotor parameters	28634
OEC/ONF-transplanted and control animals	28671
stride length	28723
speed , and base of support of the hind limbs -LRB- Fig. 3A -- C -RRB-	28744
speed	28744
base of support of the hind limbs -LRB- Fig. 3A -- C -RRB-	28755
base	28755
support of the hind limbs -LRB- Fig. 3A -- C -RRB-	28763
support	28763
the hind limbs -LRB- Fig. 3A -- C -RRB-	28774
the hind limbs	28774
Fig. 3A -- C	28790
Fig. 3A	28790
C	28798
DISCUSSION	28803
this study	28817
we	28829
a multifactorial transplantation strategy	28837
clinically relevant large lesion gaps	28889
strategy	28932
1	28954
transplantation of aligned OEC	28957
transplantation	28957
aligned OEC	28976
ONF-biomatrix complexes into 2-mm-long dorsal hemisection lesion gaps and 2 -RRB- rostral and caudal OEC/ONF injections	28989
ONF-biomatrix complexes	28989
2-mm-long dorsal hemisection lesion gaps and 2 -RRB- rostral and caudal OEC/ONF injections	29018
2-mm-long dorsal hemisection lesion gaps	29018
2 -RRB- rostral and caudal OEC/ONF injections	29063
rostral	29066
caudal OEC/ONF injections	29078
This strategy	29105
4 weeks	29134
dorsal hemisection injury	29148
we	29183
the effects of the multifactorial transplantation strategy	29205
the effects	29205
the multifactorial transplantation strategy	29220
CS axon regrowth and functional recovery	29274
axon regrowth	29277
control animals	29316
possible damage inflicted by opening of the lesion site and cellular injections during the second operation	29372
possible damage	29372
opening of the lesion site and cellular injections	29401
opening	29401
the lesion site and cellular injections	29412
the lesion site	29412
cellular injections	29432
the second operation	29459
the lesion site	29481
control animals	29516
culture medium injections	29537
the lesion site	29599
A majority of studies	29616
A majority	29616
studies	29630
promising effects of olfactory ensheathing glia	29652
promising effects	29652
olfactory ensheathing glia	29673
repair of injured CS axons	29703
repair	29703
injured CS axons	29713
small acute and chronic lesion gaps -LRB- Li et al. , 1997 , 1998 ; Ramon-Cueto et al. , 2000 ; Nash et al. , 2002 ; Keyvan-Fouladi et al. , 2003 -RRB-	29737
small acute and chronic lesion gaps	29737
Li	29774
et al. , 1997 , 1998 ; Ramon-Cueto et al. , 2000 ; Nash et al. , 2002 ; Keyvan-Fouladi et al. , 2003	29777
et al.	29777
1997 , 1998 ; Ramon-Cueto et al. , 2000 ; Nash et al. , 2002 ; Keyvan-Fouladi et al.	29785
1997 , 1998	29785
1997	29785
1998	29791
Ramon-Cueto et al. , 2000	29797
Ramon-Cueto	29797
et al. , 2000	29809
et al.	29809
2000	29817
Nash et al. , 2002	29823
Nash	29823
et al. , 2002	29828
et al.	29828
2002	29836
Keyvan-Fouladi et al.	29842
Keyvan-Fouladi	29842
et al.	29857
2003	29865
Our data	29872
the rather limited effects of a multifactorial transplantation strategy involving olfactory ensheathing on repair of chronically damaged CS axons	29886
the rather limited effects	29886
a multifactorial transplantation strategy involving olfactory ensheathing on repair of chronically damaged CS axons	29916
a multifactorial transplantation strategy	29916
olfactory ensheathing	29968
repair of chronically damaged CS axons	29993
repair	29993
chronically damaged CS axons	30003
large lesion gaps	30039
body functions	30066
It	30082
transplantation of mixed OEC/ONF cultures	30108
transplantation	30108
mixed OEC/ONF cultures	30127
regrowth of injured CS axons across small 8-week-old C1/C2 lesions interrupting the dorsal component of the CS tract unilaterally -LRB- Keyvan - Fouladi et al. , 2003 -RRB-	30161
regrowth	30161
injured CS axons across small 8-week-old C1/C2 lesions interrupting the dorsal component of the CS tract unilaterally -LRB- Keyvan - Fouladi et al. , 2003 -RRB-	30173
injured CS axons	30173
small 8-week-old C1/C2 lesions interrupting the dorsal component of the CS tract unilaterally	30197
small 8-week-old C1/C2 lesions	30197
the dorsal component of the CS tract	30241
the dorsal component	30241
the CS tract	30265
Keyvan	30292
Fouladi et al. , 2003	30300
Fouladi	30300
et al.	30308
2003	30316
these small lesions	30338
the regrowing CS axons	30359
the caudal host	30392
11 mm -LRB- Keyvan-Fouladi et al. , 2003 -RRB-	30427
11 mm	30427
Keyvan-Fouladi	30434
et al. , 2003	30449
et al.	30449
2003	30457
our study	30467
the majority of injured CS axons	30478
the majority	30478
injured CS axons	30494
the large thoracic injury site	30531
few injured CS axons	30573
the spinal gray matter	30625
the lesion site	30656
the caudal host tissue	30681
no differences	30709
OEC/ONF	30746
transplanted and control animals	30754
transplanted	30754
control animals	30771
There	30788
several issues involved in the limited effects of our strategy on CS regrowth compared with those of Keyvan-Fouladi and coworkers	30801
several issues	30801
the limited effects of our strategy on CS regrowth	30828
the limited effects	30828
our strategy on CS regrowth	30851
our strategy	30851
CS regrowth	30867
those of Keyvan-Fouladi and coworkers	30893
those	30893
Keyvan-Fouladi and coworkers	30902
Keyvan-Fouladi	30902
coworkers	30921
the level of the lesion	30939
the level	30939
the lesion	30952
involved , i.e. , low-thoracic in our study vs. high-cervical in the study of Keyvan-Fouladi and coworkers	30979
our study vs. high-cervical in the study of Keyvan-Fouladi and coworkers	31011
our study	31011
high-cervical	31025
the study	31042
Keyvan-Fouladi and coworkers	31055
Keyvan-Fouladi	31055
coworkers	31074
It	31085
larger distances between the injured axon and the soma of the	31102
larger distances	31102
the injured axon and the soma of the	31127
the injured axon	31127
the soma of the	31148
the soma	31148
the	31160
neuron result in a decreased regrowth capacity -LRB- Richardson et al. , 1984 -RRB-	31175
neuron result	31175
a decreased regrowth capacity -LRB- Richardson et al. , 1984 -RRB-	31192
a decreased regrowth capacity	31192
Richardson	31223
et al. , 1984	31234
et al.	31234
1984	31242
the lesion size	31257
a role	31291
the study of Keyvan-Fouladi and coworkers	31302
the study	31302
Keyvan-Fouladi and coworkers	31315
Keyvan-Fouladi	31315
coworkers	31334
very small lesions	31345
these lesion gaps	31387
transplanted olfactory glia -LRB- Keyvan-Fouladi et al. , 2003 -RRB-	31431
transplanted olfactory glia	31431
Keyvan-Fouladi	31460
et al. , 2003	31475
et al.	31475
2003	31483
our study	31502
a rather large lesion gap	31513
that	31547
OEC/ONF	31577
biomatrix	31599
Regrowth of severed CS axons in such a large lesion site	31610
Regrowth	31610
CS axons	31630
a large lesion site	31647
Chuah et al. , 2004	31704
Chuah	31704
et al.	31710
2004	31718
Third , the lack of survival of transplanted OEC/ONF on the biomatrix within the lesion gap	31725
Third	31725
the lack of survival of transplanted OEC/ONF on the biomatrix within the lesion gap	31732
the lack	31732
survival of transplanted OEC/ONF on the biomatrix within the lesion gap	31744
survival	31744
transplanted OEC/ONF on the biomatrix within the lesion gap	31756
transplanted OEC/ONF	31756
the biomatrix within the lesion gap	31780
the biomatrix	31780
the lesion gap	31801
the CS regrowth response	31847
Previous studies	31873
many types of growth-promoting cells	31906
many types	31906
growth-promoting cells	31920
olfactory ensheathing glia	31954
transplantation	31995
spinal injury sites -LRB- Grill et al. , 1997 ; Boyd et al. , 2004 ; Joosten et al. , 2004 -RRB-	32016
spinal injury sites	32016
Grill et al. , 1997 ; Boyd et al. , 2004 ; Joosten et al. , 2004	32037
Grill	32037
et al. , 1997 ; Boyd et al. , 2004 ; Joosten et al. , 2004	32043
et al. , 1997	32043
et al.	32043
1997	32051
Boyd et al. , 2004	32057
Boyd	32057
et al. , 2004	32062
et al.	32062
2004	32070
Joosten et al. , 2004	32076
Joosten	32076
et al. , 2004	32084
et al.	32084
2004	32092
these studies	32111
the transplanted cells	32126
the injured spinal cord environment	32184
these cells	32233
solid vehicle materials , such as collagen type I	32250
solid vehicle materials	32250
collagen type I	32283
contrast	32303
the OEC/ONF in our study	32313
the OEC/ONF	32313
our study	32328
the surface area of biodegradable poly -LRB- D , L -RRB- - lactide matrices ,	32357
the surface area of biodegradable poly -LRB- D , L -RRB-	32357
the surface area	32357
biodegradable poly -LRB- D , L -RRB-	32377
biodegradable poly	32377
lactide matrices	32401
these cells	32430
the many pathological processes	32454
the injured spinal cord environment	32499
biodegradation of poly -LRB- D , L -RRB- - lactide	32550
biodegradation	32550
poly -LRB- D , L -RRB- - lactide	32568
poly	32568
lactide	32578
a lowering of the pH , which may be detrimental to the OEC/ONF cultured on the biomatrices	32600
a lowering	32600
the pH , which may be detrimental to the OEC/ONF cultured on the biomatrices	32614
the pH	32614
the OEC/ONF cultured on the biomatrices	32650
the OEC/ONF	32650
the biomatrices	32674
OEC/ONF	32708
transplantation rostral and caudal	32725
the lesion gap	32763
they	32779
Previous work	32813
the ability of transplanted OEC/ONF	32837
the ability	32837
transplanted OEC/ONF	32852
spinal cords	32891
small lesions -LRB- Li et al. , 1998 -RRB-	32909
small lesions	32909
Li	32924
et al. , 1998	32927
et al.	32927
1998	32935
it	32946
regrowing axons	32978
transplanted olfactory glia -LRB- Ramon-Cueto et al. , 2000 -RRB-	33027
transplanted olfactory glia	33027
Ramon-Cueto	33056
et al. , 2000	33068
et al.	33068
2000	33076
our study	33086
Hoechst	33097
the transplanted OEC/ONF	33126
Hoechst	33152
leak out of prelabeled transplanted cells and staining neighboring host cells -LRB- Iwashita et al. , 2000 -RRB-	33172
leak out	33172
leak	33172
transplanted cells	33195
neighboring host cells	33227
Iwashita	33251
et al. , 2000	33260
et al.	33260
2000	33268
Hoechst-positive cells	33289
a more extensive spinal cord area than that populated by transplanted cells	33331
a more extensive spinal cord area	33331
that populated by transplanted cells	33370
that	33370
transplanted cells	33388
our study	33420
the prelabeled transplanted OEC/ONF	33431
the injection area	33486
our knowledge	33509
prelabeling cells with Hoechst	33524
prelabeling cells	33524
Hoechst	33547
cell viability or the migratory activity of cells	33590
cell viability	33590
the migratory activity of cells	33608
the migratory activity	33608
cells	33634
we	33648
the injected OEC/ONF	33669
The lack of migration of injected OEC/ONF in our study	33707
The lack	33707
migration of injected OEC/ONF in our study	33719
migration	33719
injected OEC/ONF in our study	33732
injected OEC/ONF	33732
our study	33752
the putative higher concentrations of cytotoxic substances associated with pathological processes , such as hemorrhage and inflammation , in large lesions compared with small lesions	33780
the putative higher concentrations	33780
cytotoxic substances associated with pathological processes , such as hemorrhage and inflammation , in large lesions compared with small lesions	33818
cytotoxic substances	33818
pathological processes , such as hemorrhage and inflammation , in large lesions	33855
pathological processes , such as hemorrhage and inflammation ,	33855
pathological processes	33855
hemorrhage and inflammation	33887
large lesions	33919
small lesions	33947
a result of the impaired migration of injected OEC / ONF and the absence of any surviving transplanted OEC /	33965
a result	33965
the impaired migration of injected OEC / ONF and the absence of any surviving transplanted OEC /	33977
the impaired migration	33977
injected OEC / ONF and the absence of any surviving transplanted OEC /	34003
injected OEC	34003
ONF and the absence of any surviving transplanted OEC	34017
ONF and the absence	34017
any surviving transplanted OEC	34040
any surviving	34040
OEC	34067
ONF on the biomatrices within the lesion gaps , no continuum of OEC/ONF	34072
ONF	34072
the biomatrices within the lesion gaps , no continuum of OEC/ONF	34079
the biomatrices	34079
the lesion gaps , no continuum of OEC/ONF	34102
the lesion gaps	34102
no continuum of OEC/ONF	34119
no continuum	34119
OEC/ONF	34135
the injured spinal cord	34157
The only positive effect of our strategy on CS regrowth is an enhanced presence of injured CS axons	34182
The only positive effect	34182
our strategy on CS regrowth	34210
our strategy	34210
CS regrowth	34226
an enhanced presence of injured CS axons	34241
an enhanced presence	34241
injured CS axons	34265
the lesion gap	34302
the underlying mechanisms for this effect	34327
the underlying mechanisms	34327
this effect	34357
Fifth	34395
we	34402
a shorter time of delay in OEC/ONF transplantation	34425
a shorter time	34425
delay in OEC/ONF transplantation	34443
delay	34443
OEC/ONF transplantation	34452
more robust effects on CS regrowth	34499
more robust effects	34499
CS regrowth	34522
a delay of 4 weeks	34544
a delay	34544
4 weeks	34555
a chronic spinal cord injury in rodents -LRB- Houle and Tessler , 2003 -RRB-	34592
a chronic spinal cord injury	34592
rodents -LRB- Houle and Tessler , 2003 -RRB-	34624
rodents	34624
Houle and Tessler	34633
2003	34652
the 8-week-delayed OEC/ONF transplantation that stimulated robust CS regrowth across a small spinal lesion gap -LRB- Keyvan-Fouladi et al. , 2003 -RRB-	34689
the 8-week-delayed OEC/ONF transplantation	34689
robust CS regrowth	34748
a small spinal lesion gap -LRB- Keyvan-Fouladi et al. , 2003 -RRB-	34774
a small spinal lesion gap	34774
Keyvan-Fouladi	34801
et al. , 2003	34816
et al.	34816
2003	34824
Injury to CS axons	34831
Injury	34831
CS axons	34841
a progressive die-back that renders the majority of these axons between 1 and 2.5 mm rostral to the injury site at 8 -- 10 weeks after injury -LRB- Pallini et al. , 1988 ; von Meyenburg et al. , 1998 ; Oudega et al. , 1999 -RRB-	34870
a progressive die-back	34870
the majority of these axons between 1 and 2.5 mm rostral to the injury site at 8 -- 10 weeks after injury	34906
the majority	34906
these axons between 1 and 2.5 mm rostral to the injury site at 8 -- 10 weeks after injury	34922
these axons between 1	34922
these axons	34922
1	34942
2.5 mm rostral to the injury site at 8 -- 10 weeks after injury	34948
2.5 mm rostral to the injury site at 8	34948
2.5 mm rostral	34948
the injury site at 8	34966
the injury site	34966
8	34985
10 weeks after injury	34987
10 weeks	34987
injury	35002
Pallini et al. , 1988 ; von Meyenburg et al. , 1998 ; Oudega et al. , 1999	35010
Pallini	35010
et al. , 1988 ; von Meyenburg et al. , 1998 ; Oudega et al. , 1999	35018
et al. , 1988	35018
et al.	35018
1988	35026
von Meyenburg et al. , 1998	35032
von Meyenburg	35032
et al. , 1998	35046
et al.	35046
1998	35054
Oudega et al. , 1999	35060
Oudega	35060
et al. , 1999	35067
et al.	35067
1999	35075
Die-back of injured CS axons beyond 1 mm rostral to the injury site	35082
Die-back	35082
injured CS axons beyond 1 mm rostral to the injury site	35094
injured CS axons	35094
1 mm rostral to the injury site	35118
1 mm rostral	35118
the injury site	35134
more than 4 weeks	35170
OEC/ONF	35197
1 mm rostral to the lesion gap	35222
1 mm rostral	35222
the lesion gap	35238
4 weeks	35256
injury	35270
the transplanted OEC/ONF	35278
reach of the injured CS axons	35321
reach	35321
the injured CS axons	35330
Spontaneous sprouting responses of injured CS axons	35352
Spontaneous sprouting responses	35352
injured CS axons	35387
between 2 and 13 weeks	35410
injury -LRB- Li and Raisman , 1995 ; Hill et al. , 2001 -RRB-	35439
injury	35439
Li and Raisman , 1995 ; Hill et al. , 2001	35447
Li and Raisman	35447
1995 ; Hill et al.	35463
1995	35463
Hill et al.	35469
Hill	35469
et al.	35474
2001	35482
both spontaneous die-back and sprouting responses of injured CS axons	35496
both spontaneous die-back	35496
sprouting responses	35526
injured CS axons	35549
the rostrally injected OEC/ONF	35596
The interrupted and branched appearance of the injured CS axons	35628
The interrupted and branched appearance	35628
the injured CS axons	35671
the injury suggests that these axons displayed a strong sprouting response	35712
the injury	35712
these axons	35737
a strong	35759
response	35778
we	35797
GAP43/B50 , a growthassociated protein -LRB- Strittmatter et al. , 1992 -RRB- ,	35824
GAP43/B50	35824
a growthassociated protein -LRB- Strittmatter et al. , 1992 -RRB-	35835
a growthassociated protein	35835
Strittmatter	35863
et al. , 1992	35876
et al.	35876
1992	35884
these injured CS axons	35894
these	35894
CS axons	35908
it	35932
the OEC/ONF	35959
rostral to the lesion gap	35980
rostral	35980
the lesion gap	35991
an initial sprouting response of injured CS axons that subsided 12 weeks later when the animals were sacrificed	36014
an initial sprouting response	36014
injured CS axons	36047
12 weeks later	36078
the animals	36098
The transplanted prelabeled OEC/ONF	36127
rostral to the lesion gap	36172
rostral	36172
the lesion gap	36183
the injection areas	36226
1 mm rostral to the lesion gap	36249
1 mm rostral	36249
the lesion gap	36265
The injured CS axons	36281
the lesion gap	36323
its rostral edge	36352
the response of injured CS axons to OEC/ONF treatment	36377
the response	36377
injured CS axons to OEC/ONF treatment	36393
injured CS axons	36393
OEC/ONF treatment	36413
the release of diffusible neurotrophic factors	36461
the release	36461
diffusible neurotrophic factors	36476
the OEC / ONF	36511
the OEC	36511
ONF	36520
Neurotrophin-3 -LRB- NT-3 -RRB-	36525
Neurotrophin-3	36525
NT-3	36541
a putative diffusible neurotrophic factor mediating this OEC/ONF effect , insofar as NT-3 injection rostral to a dorsal hemisection injury site has been shown to stimulate a strong sprouting response of injured CS axons -LRB- Schnell et al. , 1994 -RRB-	36550
a putative diffusible neurotrophic factor	36550
this OEC/ONF effect	36602
NT-3 injection rostral to a dorsal hemisection injury site has been shown to stimulate a strong sprouting response of injured CS axons	36634
NT-3 injection rostral	36634
a dorsal hemisection injury site has been shown to stimulate a strong sprouting response of injured CS axons	36660
a dorsal hemisection	36660
injury site	36681
a strong sprouting response of injured CS axons	36721
a strong sprouting response	36721
injured CS axons	36752
Schnell	36770
et al. , 1994	36778
et al.	36778
1994	36786
The expression of NT-3 by adult OEC	36793
The expression	36793
NT-3 by adult OEC	36811
NT-3	36811
adult OEC	36819
Ramon - Cueto and Avila , 1998	36853
Ramon	36853
Cueto and Avila , 1998	36860
Cueto and Avila	36860
1998	36877
The main focus of our study	36884
The main focus	36884
our study	36902
regrowth of the injured CS tract	36919
regrowth	36919
the injured CS tract	36931
we	36964
the effects of the transplantation strategy	37009
the effects	37009
the transplantation strategy	37024
the stride length of the hind limbs , which may be linked to the CS tract -LRB- Bregman et al. , 1995 ; Starkey et al. , 2005 -RRB-	37056
the stride length	37056
the hind limbs , which may be linked to the CS tract -LRB- Bregman et al. , 1995 ; Starkey et al. , 2005 -RRB-	37077
the hind limbs	37077
the CS tract -LRB- Bregman et al. , 1995 ; Starkey et al. , 2005 -RRB-	37116
the CS tract	37116
Bregman	37130
et al. , 1995 ; Starkey et al. , 2005	37138
et al.	37138
1995 ; Starkey et al.	37146
1995	37146
Starkey et al.	37152
Starkey	37152
et al.	37160
2005	37168
the lowthoracic spinal cord of the rats in this study	37208
the lowthoracic spinal cord	37208
the rats in this study	37239
the rats	37239
this study	37251
the stride length of the hind limbs	37277
the stride length	37277
the hind limbs	37298
These results	37314
the relation between the CS tract and stride length of the hind limbs	37341
the relation	37341
the CS tract and stride length of the hind limbs	37362
the CS tract and stride length	37362
the hind limbs	37396
other axon tracts	37433
A locomotor parameter affected after dorsal hemisection	37452
A locomotor parameter	37452
dorsal hemisection	37489
the base of support of the hind limbs -LRB- Joosten et al. , 2004 -RRB-	37511
the base	37511
support of the hind limbs -LRB- Joosten et al. , 2004 -RRB-	37523
support	37523
the hind limbs -LRB- Joosten et al. , 2004 -RRB-	37534
the hind limbs	37534
Joosten	37550
et al. , 2004	37558
et al.	37558
2004	37566
no recovery	37588
this loco - motor parameter in OEC/ONF-transplanted vs. control animals	37613
this loco	37613
motor parameter in OEC/ONF-transplanted vs. control animals	37624
motor parameter	37624
OEC/ONF-transplanted vs. control animals	37643
OEC/ONF-transplanted	37643
control animals	37668
The relatively minor behavioral impairment after dorsal hemisection injury	37685
The relatively minor behavioral impairment	37685
dorsal hemisection injury	37734
further substantiated by the results on the BBB locomotor rating scale	37763
further	37763
the results on the BBB locomotor rating scale	37788
the results	37788
the BBB locomotor rating scale	37803
the CatWalk-related regularity index , an objective and sensitive measure for coordination ,	37840
the CatWalk-related regularity index	37840
an objective and sensitive measure for coordination	37878
an objective and sensitive measure	37878
coordination	37917
the BBB score	37952
Koopmans et al. , 2005	37992
Koopmans	37992
et al.	38001
2005	38009
BBB scores	38016
15	38051
This	38055
the window for functional recovery after dorsal hemisection injury	38073
the window	38073
functional recovery after dorsal hemisection injury	38088
functional recovery	38088
dorsal hemisection injury	38114
only locomotor parameters such as paw rotation , toe clearance , and base of support of the hind limbs	38165
only locomotor parameters	38165
paw rotation , toe clearance , and base of support of the hind limbs	38199
paw rotation	38199
toe clearance	38213
base of support of the hind limbs	38232
base	38232
support of the hind limbs	38240
support	38240
the hind limbs	38251
conclusion	38270
our multifactorial transplantation strategy	38282
regrowth of injured CS axons	38344
regrowth	38344
injured CS axons	38356
large lesion gaps	38380
OEC/ONF injections	38407
regrowth of injured CS axons	38448
regrowth	38448
injured CS axons	38460
small spinal lesion gaps	38484
it	38510
large lesion gaps	38535
small spinal lesion gaps	38576
Most axon-regrowth-promoting strategies	38602
animal models of SCI	38656
animal models	38656
SCI	38673
relatively small spinal lesion gaps	38682
spinal lesion gaps in humans	38727
spinal lesion gaps	38727
humans	38749
it	38780
strategies that stimulated axon regrowth across small lesion sites in animals	38812
strategies	38812
axon regrowth	38839
small lesion sites	38860
animals	38882
a clinical setting	38919
the large lesion gap	38950
we	38985
the dorsal hemisection lesion model	39002
regrowth of injured axons	39063
regrowth	39063
injured axons	39075
functional recovery	39131
the associated limited behavioral impairment	39163
Future studies	39209
optimization of the multifactorial transplantation strategy	39246
optimization	39246
the multifactorial transplantation strategy	39262
regrowth of injured CS axons	39319
regrowth	39319
injured CS axons	39331
large spinal lesion gaps	39355
ACKNOWLEDGMENTS The authors	39382
ACKNOWLEDGMENTS	39382
The authors	39398
Dr. Y. Li and Prof.Dr	39416
Dr. Y. Li	39416
Prof.Dr	39430
G. Raisman for extending their knowledge on culturing of OEC/ONF to our laboratory .	39439
G. Raisman	39439
their knowledge	39464
culturing of OEC/ONF	39483
culturing	39483
OEC/ONF	39496
our laboratory	39507
The authors	39523
Lou Kirkels -LRB- IDEE , Maastricht -RRB- for his expertise with respect	39556
Lou Kirkels -LRB- IDEE , Maastricht -RRB-	39556
Lou Kirkels	39556
IDEE	39569
Maastricht	39575
his expertise with respect	39591
his expertise	39591
respect	39610
the injection procedures	39621
The RT97 monoclonal antibody , developed by Dr. J. Wood ,	39647
The RT97 monoclonal antibody	39647
Dr. J. Wood	39690
the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD	39721
the Developmental Studies	39721
Hybridoma Bank	39747
the auspices of the NICHD	39778
the auspices	39778
the NICHD	39794
The University of Iowa Department of Biological Sciences	39822
The University	39822
Iowa Department of Biological Sciences	39840
Iowa Department	39840
Biological Sciences	39859
This work	39880
the International Spinal Research Trust -LRB- ISRT ; grant STR057 to E.A.J.J. -RRB-	39904
the International Spinal Research Trust	39904
ISRT ; grant STR057 to E.A.J.J.	39945
ISRT	39945
grant STR057 to E.A.J.J.	39951
grant STR057	39951
E.A.J.J.	39967
REFERENCES Basso DM , Beattie MS , Bresnahan JC .	39979
REFERENCES	39979
Basso DM , Beattie MS , Bresnahan JC	39990
Basso DM	39990
Beattie MS	40000
Bresnahan JC	40012
1995	40026
A sensitive and reliable locomotor rating scale for open field testing in rats .	40032
A sensitive and reliable locomotor	40032
rating scale for open field testing in rats	40067
rating scale	40067
open field testing in rats	40084
open field testing	40084
rats	40106
J Neurotrauma 12:1 -- 21 .	40112
J Neurotrauma 12:1	40112
21	40131
Boyd JG , Lee J , Skihar V , Doucette R , Kawaja MD. 2004 .	40135
Boyd JG	40135
Lee J	40144
Skihar V	40151
Doucette R	40161
Kawaja MD. 2004	40173
Kawaja MD.	40173
2004	40184
LacZ-expressing olfactory ensheathing cells	40190
not associate with myelinated axons after implantation	40237
not associate	40237
myelinated axons after implantation	40256
myelinated axons	40256
implantation	40279
the compressed spinal cord	40297
Proc Natl Acad Sci U S A 101:2162 -- 2166 .	40325
Proc Natl Acad Sci U S A 101:2162	40325
2166	40359
Bregman BS , Kunkel-Bagden E , Schnell L , Dai HN , Gao D , Schwab ME .	40365
Bregman BS	40365
Kunkel-Bagden E , Schnell L , Dai HN , Gao D , Schwab ME	40377
Kunkel-Bagden E	40377
Schnell L	40394
Dai HN	40405
Gao D	40413
Schwab ME	40420
1995	40431
Recovery from spinal cord injury	40437
Recovery	40437
spinal cord injury	40451
antibodies to neurite growth inhibitors	40482
antibodies	40482
neurite growth inhibitors	40496
Nature 378:498 -- 501 .	40523
Nature 378:498	40523
501	40538
Chuah MI , Choi-Lundberg D , Weston S , Vincent AJ , Chung RS , Vickers JC , West AK .	40543
Chuah MI	40543
Choi-Lundberg D , Weston S , Vincent AJ , Chung RS , Vickers JC , West AK	40553
Choi-Lundberg D	40553
Weston S	40570
Vincent AJ	40580
Chung RS	40592
Vickers JC	40602
West AK	40614
2004	40623
Olfactory ensheathing cells	40629
collateral	40665
the injured adult rat spinal cord	40696
Exp Neurol 185:15 -- 25 .	40731
Exp Neurol 185:15	40731
25	40749
Deumens R , Koopmans GC , Den Bakker CG , Maquet V , Blacher S , Honig WM , Jerome R , Pirard JP , Steinbusch HW , Joosten EA .	40753
Deumens	40753
R , Koopmans GC , Den Bakker CG , Maquet V , Blacher S , Honig WM , Jerome R , Pirard JP , Steinbusch HW , Joosten EA	40761
R	40761
Koopmans GC	40764
Den Bakker CG	40777
Maquet V	40792
Blacher S	40802
Honig WM	40813
Jerome R	40823
Pirard JP	40833
Steinbusch HW	40844
Joosten EA	40859
2004	40871
Alignment of glial cells	40877
Alignment	40877
glial cells	40890
directional neurite growth of CNS neurons	40913
directional neurite growth	40913
CNS neurons	40943
Neuroscience 125:591 -- 604 .	40965
Neuroscience 125:591	40965
604	40986
Dusart I , Schwab ME .	40991
Dusart I	40991
Schwab ME	41001
1994	41012
Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord .	41018
Secondary cell	41018
death and the inflammatory reaction	41033
death	41033
the inflammatory reaction	41043
dorsal hemisection of the rat spinal cord	41075
dorsal hemisection	41075
the rat spinal cord	41097
Eur J Neurosci 6:712 -- 724 .	41118
Eur J Neurosci 6:712	41118
724	41139
Franceschini IA , Barnett SC .	41144
Franceschini IA	41144
Barnett SC	41161
1996	41173
Low-affinity NGF-receptor and E-NCAM expression	41179
Low-affinity NGF-receptor	41179
E-NCAM expression	41209
two types of olfactory nerve ensheathing cells that share a common lineage	41234
two types	41234
olfactory nerve ensheathing cells	41247
a common lineage	41292
Dev Biol 173:327 -- 343 .	41310
Dev Biol 173:327	41310
343	41327
Goldshmit Y , Galea MP , Wise G , Bartlett PF , Turnley AM .	41332
Goldshmit Y	41332
Galea MP	41345
Wise G	41355
Bartlett PF	41363
Turnley AM	41376
2004	41388
Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice .	41394
Axonal regeneration and lack	41394
astrocytic gliosis	41426
EphA4-deficient mice	41448
J Neurosci 24:10064 -- 10073 .	41470
J Neurosci 24:10064	41470
10073	41490
Grill R , Blesch A , Gage FH , Tuszynski MH .	41497
Grill R	41497
Blesch A	41506
Gage FH	41516
Tuszynski MH	41525
1997	41539
Cellular delivery of neurotrophin-3	41545
Cellular delivery	41545
neurotrophin-3	41566
corticospinal axonal growth and partial functional recovery	41590
axonal growth	41604
spinal cord injury	41656
J Neurosci 17:5560 -- 5572 .	41676
J Neurosci 17:5560	41676
5572	41695
Hamers FP , Lankhorst AJ , van Laar TJ , Veldhuis WB , Gispen WH .	41701
Hamers FP	41701
Lankhorst AJ	41712
van Laar TJ	41726
Veldhuis WB	41739
Gispen WH	41752
2001	41763
Automated quantitative gait analysis during overground locomotion in the rat : its application to spinal cord contusion and transection injuries .	41769
Automated quantitative gait analysis during overground locomotion in the rat	41769
Automated quantitative gait analysis	41769
overground locomotion	41813
the rat	41838
its application to spinal cord contusion and transection injuries	41847
its application	41847
spinal cord contusion and transection injuries	41866
J Neurotrauma 18:187 -- 201 .	41914
J Neurotrauma	41914
18:187 -- 201	41928
Hill CE , Beattie MS , Bresnahan JC .	41940
Hill CE	41940
Beattie MS , Bresnahan JC	41949
Beattie MS	41949
Bresnahan JC	41961
2001	41975
Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat .	41981
Degeneration and sprouting of	41981
Degeneration	41981
supraspinal axons	42033
contusive spinal cord injury in the rat	42057
contusive spinal cord injury	42057
the rat	42089
Exp Neurol 171:153 -- 169 .	42098
Exp Neurol 171:153	42098
169	42117
Houle JD , Tessler A. 2003 .	42122
Houle JD	42122
Tessler A. 2003	42132
Tessler A.	42132
2003	42143
Repair of chronic spinal cord injury .	42149
Repair	42149
chronic spinal cord injury	42159
Exp Neurol 182:247 -- 260 .	42187
Exp Neurol	42187
182:247 -- 260	42198
Houle JD , Schramm P , Herdegen T. 1998 .	42211
Houle JD	42211
Schramm P	42221
Herdegen T. 1998	42232
Herdegen T.	42232
1998	42244
Trophic factor modulation of c-Jun expression in supraspinal neurons after chronic spinal cord injury .	42250
Trophic factor modulation	42250
c-Jun expression	42279
supraspinal neurons	42299
chronic spinal cord injury	42325
Exp Neurol 154:602 -- 611 .	42353
Exp Neurol 154:602	42353
611	42372
Iwashita Y , Crang AJ , Blakemore WF .	42377
Iwashita Y	42377
Crang AJ , Blakemore WF	42389
Crang AJ	42389
Blakemore WF	42399
2000	42413
Redistribution of bisbenzimide Hoechst 33342 from transplanted cells to host cells .	42419
Redistribution	42419
bisbenzimide Hoechst 33342 from transplanted cells to host cells	42437
bisbenzimide	42437
Hoechst 33342	42450
transplanted cells to host cells	42469
transplanted cells	42469
host cells	42491
Neuroreport 11:1013 -- 1016 .	42503
Neuroreport 11:1013	42503
1016	42523
Joosten EA , Veldhuis WB , Hamers FP .	42529
Joosten EA	42529
Veldhuis WB , Hamers FP	42541
Veldhuis WB	42541
Hamers FP	42554
2004	42565
Collagen containing neonatal astrocytes	42571
Collagen	42571
neonatal astrocytes	42591
regrowth of injured fibers	42622
regrowth	42622
injured fibers	42634
modest locomotor recovery	42662
spinal cord injury	42694
J Neurosci Res 77:127 -- 142 .	42714
J Neurosci Res 77:127	42714
142	42736
Keyvan-Fouladi N , Raisman G , Li Y. 2003 .	42741
Keyvan-Fouladi N	42741
Raisman G , Li Y. 2003	42759
Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats .	42782
Functional repair	42782
the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats	42803
the corticospinal tract	42803
delayed transplantation of olfactory ensheathing cells in adult rats	42830
delayed transplantation	42830
olfactory ensheathing cells in adult rats	42857
olfactory ensheathing cells	42857
adult rats	42888
J Neurosci 23:9428 -- 9434 .	42900
J Neurosci 23:9428	42900
9434	42919
Koopmans GC , Deumens R , Honig WM , Hamers FP , Steinbusch HW , Joosten EA .	42925
Koopmans GC	42925
Deumens R , Honig WM , Hamers FP , Steinbusch HW , Joosten EA	42938
Deumens R	42938
Honig WM	42949
Hamers FP	42959
Steinbusch HW	42970
Joosten EA	42985
2005	42997
The assessment of locomotor function in spinal cord injured rats : the importance of objective analysis of coordination .	43003
The assessment of locomotor function in spinal cord injured rats	43003
The assessment	43003
locomotor function in spinal cord injured rats	43021
locomotor function	43021
spinal cord injured rats	43043
spinal cord	43043
rats	43063
the importance of objective analysis of coordination	43069
the importance	43069
objective analysis of coordination	43087
objective analysis	43087
coordination	43109
J Neurotrauma 22:214 -- 225 .	43123
J Neurotrauma 22:214	43123
225	43144
Kost SA , Oblinger MM .	43149
Kost SA	43149
Oblinger MM	43158
1993	43171
Immature corticospinal neurons	43177
changes in tubulin gene expression	43232
changes	43232
tubulin gene expression	43243
Brain Res Bull 30 : 469 -- 475 .	43268
Brain Res Bull 30	43268
469 -- 475	43287
Li Y , Raisman G. 1995 .	43296
Li Y	43296
Raisman G. 1995	43302
Raisman G.	43302
1995	43313
Sprouts from cut corticospinal axons	43319
Sprouts	43319
cut corticospinal axons	43332
the presence of astrocytic scarring	43367
the presence	43367
astrocytic scarring	43383
long-term lesions of the adult rat spinal cord	43406
long-term lesions	43406
the adult rat spinal cord	43427
Exp Neurol 134:102 -- 111 .	43454
Exp Neurol 134:102	43454
111	43473
Li Y , Field PM , Raisman G. 1997 .	43478
Li Y	43478
Field PM , Raisman G. 1997	43484
Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells .	43511
Repair	43511
adult rat corticospinal tract	43521
transplants of olfactory ensheathing cells	43554
transplants	43554
olfactory ensheathing cells	43569
Science 277:2000 -- 2002 .	43598
Science 277:2000	43598
2002	43615
Li Y , Field PM , Raisman G. 1998 .	43621
Li Y	43621
Field PM , Raisman G. 1998	43627
Regeneration of adult rat corticospinal axons	43654
Regeneration	43654
adult rat corticospinal axons	43670
adult rat	43670
corticospinal axons	43680
transplanted olfactory ensheathing cells	43711
transplanted olfactory ensheathing	43711
cells	43746
J Neurosci 18 : 10514 -- 10524 .	43753
J Neurosci 18	43753
10514 -- 10524	43768
Li Y , Decherchi P , Raisman G. 2003 .	43781
Li Y	43781
Decherchi P	43787
Raisman G. 2003	43800
Raisman G.	43800
2003	43811
Transplantation of olfactory ensheathing cells into spinal cord lesions	43817
Transplantation	43817
olfactory ensheathing cells into spinal cord lesions	43836
olfactory ensheathing cells	43836
spinal cord lesions	43869
breathing and climbing	43898
J Neurosci 23:727 -- 731 .	43922
J Neurosci 23:727	43922
731	43940
Li Y , Field PM , Raisman G. 2005 .	43945
Li Y	43945
Field PM , Raisman G. 2005	43951
Olfactory ensheathing cells and olfactory nerve fibroblasts	43978
Olfactory ensheathing cells	43978
olfactory nerve fibroblasts	44010
continuous open channels for regrowth of olfactory nerve fibres	44047
continuous open channels	44047
regrowth of olfactory nerve fibres	44076
regrowth	44076
olfactory nerve fibres	44088
Glia -LRB- in press -RRB- .	44112
Glia	44112
press	44121
Lu J , Feron F , Ho SM , Mackay-Sim A , Waite PM .	44129
Lu J	44129
Feron F	44135
Ho SM	44144
Mackay-Sim A	44151
Waite PM	44165
2001	44175
Transplantation of nasal olfactory tissue	44181
Transplantation	44181
nasal olfactory tissue	44200
partial recovery in paraplegic adult rats	44232
partial recovery	44232
paraplegic adult rats	44252
Brain Res 889:344 -- 357 .	44275
Brain Res 889:344	44275
Brain	44275
Res 889:344	44281
357	44293
Nash HH , Borke RC , Anders JJ .	44298
Nash HH	44298
Borke RC , Anders JJ	44307
Borke RC	44307
Anders JJ	44317
2002	44328
Ensheathing cells and methylprednisolone	44334
Ensheathing cells	44334
methylprednisolone	44356
axonal regeneration and functional recovery in the lesioned adult rat spinal cord	44383
axonal regeneration and functional recovery	44383
the lesioned adult rat spinal cord	44430
J Neurosci 22:7111 -- 7120 .	44466
J Neurosci 22:7111	44466
7120	44485
Oudega M , Vargas CG , Weber AB , Kleitman N , Bunge MB .	44491
Oudega M	44491
Vargas CG	44501
Weber AB	44512
Kleitman N	44522
Bunge MB	44534
1999	44544
Long-term effects of methylprednisolone following transection of adult rat spinal cord .	44550
Long-term effects	44550
methylprednisolone following transection of adult rat spinal cord	44571
methylprednisolone following transection	44571
adult rat spinal cord	44615
Eur J Neurosci 11:2453 -- 2464 .	44638
Eur J Neurosci 11:2453	44638
2464	44661
Pallini R , Fernandez E , Sbriccoli A. 1988 .	44667
Pallini R	44667
Fernandez E , Sbriccoli A. 1988	44678
Retrograde degeneration of corticospinal axons following transection of the spinal cord in rats .	44710
Retrograde degeneration	44710
corticospinal axons following transection of the spinal cord in rats	44737
corticospinal axons	44737
transection of the spinal cord in rats	44767
transection	44767
the spinal cord in rats	44782
the spinal cord	44782
rats	44801
A quantitative study with anterogradely	44807
A quantitative study	44807
anterogradely	44833
horseradish peroxidase	44859
J Neurosurg 68:124 -- 128 .	44883
J Neurosurg 68:124	44883
128	44902
Ramon-Cueto A , Avila J. 1998 .	44907
Ramon-Cueto A	44907
Avila J. 1998	44922
Avila J.	44922
1998	44931
Olfactory ensheathing glia : properties and function .	44937
Olfactory ensheathing glia	44937
properties and function	44965
properties	44965
function	44980
Brain Res Bull 46:175 -- 187 .	44990
Brain Res Bull 46:175	44990
187	45012
Ramon-Cueto A , Nieto-Sampedro M. 1992 .	45017
Ramon-Cueto A	45017
Nieto-Sampedro M. 1992	45032
Nieto-Sampedro M.	45032
1992	45050
Glial cells from adult rat olfactory bulb : immunocytochemical properties of pure cultures of ensheathing cells .	45056
Glial cells from adult rat olfactory bulb	45056
Glial cells	45056
adult rat olfactory bulb	45073
immunocytochemical properties of pure cultures of ensheathing cells	45099
immunocytochemical properties	45099
pure cultures of ensheathing cells	45132
pure cultures	45132
ensheathing cells	45149
Neuroscience 47:213 -- 220 .	45168
Neuroscience 47:213	45168
220	45188
Ramon-Cueto A , Cordero MI , Santos-Benito FF , Avila J. 2000 .	45193
Ramon-Cueto A	45193
Cordero MI	45208
Santos-Benito FF	45220
Avila J. 2000	45238
Avila J.	45238
2000	45247
Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia .	45253
Functional recovery	45253
paraplegic rats and motor axon regeneration	45276
paraplegic rats	45276
motor axon regeneration	45296
their spinal cords	45323
olfactory ensheathing glia	45345
Neuron 25:425 -- 435 .	45373
Neuron 25:425	45373
435	45387
Richardson PM , Issa VM , Aguayo AJ .	45392
Richardson PM	45392
Issa VM , Aguayo AJ	45407
Issa VM	45407
Aguayo AJ	45416
1984	45427
Regeneration of long spinal axons in the rat .	45433
Regeneration	45433
long spinal axons	45449
the rat	45470
J Neurocytol 13:165 -- 182 .	45479
J Neurocytol 13:165	45479
182	45499
Schnell L , Schneider R , Kolbeck R , Barde YA , Schwab ME .	45504
Schnell L	45504
Schneider R	45515
Kolbeck R	45528
Barde YA	45539
Schwab ME	45549
1994	45560
Neurotrophin	45566
3	45580
corticospinal tract	45604
development	45631
adult spinal cord lesion	45653
Nature 367:170 -- 173 .	45679
Nature 367:170	45679
173	45694
Schwab ME , Bartholdi D. 1996 .	45699
Schwab ME	45699
Bartholdi D. 1996	45710
Bartholdi D.	45710
1996	45723
Degeneration and regeneration of axons in the lesioned spinal cord .	45729
Degeneration and regeneration of axons in the lesioned spinal cord	45729
Degeneration	45729
regeneration of axons in the lesioned spinal cord	45746
regeneration	45746
axons in the lesioned spinal cord	45762
axons	45762
the lesioned spinal cord	45771
Physiol Rev 76:319 -- 370 .	45797
Physiol Rev 76:319	45797
370	45816
Silver J , Miller JH .	45821
Silver J	45821
Miller JH	45831
2004	45842
Regeneration beyond the glial scar .	45848
Regeneration	45848
the glial scar	45868
Nat Rev Neurosci 5:146 -- 156 .	45884
Nat Rev Neurosci	45884
5:146 -- 156	45901
Skene JH .	45912
1989	45922
Axonal growth-associated proteins .	45928
Axonal	45928
growth-associated proteins	45935
Annu Rev Neurosci 12:127 -- 156 .	45963
Annu Rev Neurosci	45963
12:127 -- 156	45981
Starkey ML , Barritt AW , Yip PK , Davies M , Hamers FP , McMahon SB , Bradbury EJ .	45993
Starkey ML	45993
Barritt AW , Yip PK , Davies M , Hamers FP , McMahon SB , Bradbury EJ	46005
Barritt AW	46005
Yip PK	46017
Davies M	46025
Hamers FP	46035
McMahon SB	46046
Bradbury EJ	46058
2005	46071
behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice	46087
behavioural function	46087
a pyramidotomy lesion of the corticospinal tract in adult mice	46118
a pyramidotomy lesion	46118
the corticospinal tract in adult mice	46143
the corticospinal tract	46143
adult mice	46170
Exp Neurol 195 : 524 -- 539 .	46182
Exp Neurol 195	46182
Exp Neurol	46182
195	46193
524 -- 539	46198
Strittmatter SM , Vartanian T , Fishman MC .	46207
Strittmatter SM	46207
Vartanian T , Fishman MC	46224
Vartanian T	46224
Fishman MC	46237
1992	46249
GAP-43 as a plasticity protein in neuronal form and repair .	46255
GAP-43	46255
a plasticity protein	46265
neuronal form and repair	46289
J Neurobiol 23:507 -- 520 .	46315
J Neurobiol 23:507	46315
520	46334
Tang X , Davies JE , Davies SJ .	46339
Tang X	46339
Davies JE , Davies SJ	46347
Davies JE	46347
Davies SJ	46358
2003	46369
Changes in distribution , cell associations , and protein expression levels of NG2 , neurocan , phosphacan , brevican , versican V2 , and tenascin-C during acute to chronic maturation of spinal cord scar tissue .	46375
Changes	46375
distribution , cell associations , and protein expression levels of NG2 , neurocan , phosphacan , brevican , versican V2 , and tenascin-C	46386
distribution	46386
cell associations	46400
protein expression levels of NG2 , neurocan , phosphacan , brevican , versican V2	46423
protein expression levels	46423
NG2 , neurocan , phosphacan , brevican , versican V2	46452
tenascin-C	46506
acute to chronic maturation of spinal cord scar tissue	46524
chronic maturation of spinal cord scar	46533
chronic maturation	46533
spinal cord scar	46555
J Neurosci Res 71:427 -- 444 .	46580
J Neurosci Res 71:427	46580
444	46602
Tetzlaff W , Alexander SW , Miller FD , Bisby MA .	46607
Tetzlaff W	46607
Alexander SW	46619
Miller FD	46633
Bisby MA	46644
1991	46654
Response of facial and rubrospinal neurons to axotomy : changes in mRNA expression for cytoskeletal proteins and GAP-43 .	46660
Response of facial and rubrospinal neurons to axotomy	46660
Response	46660
facial and rubrospinal neurons	46672
axotomy	46706
changes in mRNA expression for cytoskeletal proteins and GAP-43	46715
changes	46715
mRNA expression for cytoskeletal proteins and GAP-43	46726
mRNA expression	46726
cytoskeletal proteins and GAP-43	46746
J Neurosci 11:2528 -- 2544 .	46780
J Neurosci 11:2528	46780
2544	46799
von Meyenburg J , Brosamle C , Metz GA , Schwab ME .	46805
von Meyenburg J	46805
Brosamle C	46822
Metz GA	46834
Schwab ME	46843
1998	46854
Regeneration and sprouting of chronically injured corticospinal tract fibers in adult rats promoted by NT-3 and the mAb IN-1 , which neutralizes myelinassociated neurite growth inhibitors .	46860
Regeneration and sprouting of chronically injured corticospinal tract fibers	46860
Regeneration and sprouting	46860
chronically injured corticospinal tract fibers	46890
adult rats promoted by NT-3 and the mAb IN-1 , which neutralizes myelinassociated neurite growth inhibitors	46940
adult rats	46940
NT-3 and the mAb IN-1	46963
NT-3	46963
the mAb IN-1	46972
myelinassociated neurite growth inhibitors	47004
Exp Neurol 154:583 -- 594 .	47048
Exp Neurol 154:583	47048
594	47067
